var title_f40_60_41920="Diclofenac: Patient drug information";
var content_f40_60_41920=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"13\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Diclofenac: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <div class=\"block note\" id=\"F12804605\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <p>",
"     Information for this drug is presented separately based upon the following methods of administration:",
"    </p>",
"   </div>",
"   <div class=\"sec_xr rmolist\" id=\"F12804606\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <ul xmlns=\"\">",
"     <li>",
"      <a class=\"drug drug_patient\" href=\"mobipreview.htm?9/51/10036?source=see_link\">",
"       Diclofenac (ophthalmic): Patient drug information",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_patient\" href=\"mobipreview.htm?20/32/20998?source=see_link\">",
"       Diclofenac (systemic): Patient drug information",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_patient\" href=\"mobipreview.htm?2/29/2518?source=see_link\">",
"       Diclofenac (topical): Patient drug information",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12371 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-202.43.93.2-04D01F2D42-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_60_41920=[""].join("\n");
var outline_f40_60_41920=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   DRUG INFORMATION",
"   <br/>",
"   [by method of administration]",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?9/51/10036?source=related_link\">",
"      Diclofenac (ophthalmic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?20/32/20998?source=related_link\">",
"      Diclofenac (systemic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?2/29/2518?source=related_link\">",
"      Diclofenac (topical): Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_60_41921="Humeral fracture proximal one-part";
var content_f40_60_41921=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F64768&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F64768&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    One part fracture of the proximal humerus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This radiograph shows a nondisplaced, one-part fracture (arrows) at the surgical neck of the proximal humerus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Rebecca Bassett, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_60_41921=[""].join("\n");
var outline_f40_60_41921=null;
var title_f40_60_41922="Rectal prolapse - complete";
var content_f40_60_41922=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F52071&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F52071&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Rectal prolapse - complete",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This picture shows a full thickness, complete rectal prolapse.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_60_41922=[""].join("\n");
var outline_f40_60_41922=null;
var title_f40_60_41923="Complete placenta previa";
var content_f40_60_41923=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F74665&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F74665&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Complete placenta previa",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 415px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Transabdominal study shows the placenta completely covering the internal os (arrow). A central placenta previa occurs when the internal os is approximately equidistant from the anterior and posterior placental edges; 20&nbsp;to 30 percent of complete previas are central.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Deborah Levine, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_60_41923=[""].join("\n");
var outline_f40_60_41923=null;
var title_f40_60_41924="Clobazam: Patient drug information";
var content_f40_60_41924=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Clobazam: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/49/40727?source=see_link\">",
"     see \"Clobazam: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?32/4/32839?source=see_link\">",
"     see \"Clobazam: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F13688779\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Onfi&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F152592\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Clobazam&reg;;",
"     </li>",
"     <li>",
"      Clobazam-10;",
"     </li>",
"     <li>",
"      Dom-Clobazam;",
"     </li>",
"     <li>",
"      Frisium&reg;;",
"     </li>",
"     <li>",
"      Novo-Clobazam;",
"     </li>",
"     <li>",
"      PMS-Clobazam",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F11263350\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10017293\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691482",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop or control seizures.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10017292\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701830",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to clobazam or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10017297\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697693",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may be habit-forming with long-term use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697180",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have been taking this drug for more than 10 days, talk with your doctor before stopping. You may want to slowly stop this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697300",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have lung disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697307",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have mental illness, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4128402",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you drink grapefruit juice or eat grapefruit often, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, mixed drinks, or other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696708",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Birth control pills and other hormone-based birth control may not work to stop pregnancy. Use 2 kinds of birth control while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10017298\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698074",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697975",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698162",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to sleep.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10017300\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699075",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of low mood (depression), thoughts of killing yourself, nervousness, emotional ups and downs, thinking that is not normal, anxiety, or lack of interest in life.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699057",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Big change in balance.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698512",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If seizures are worse or not the same after starting this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10017295\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3620325",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tablet may be crushed and mixed with applesauce.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10017296\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10017301\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10017302\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11705 Version 38.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-122.72.76.133-8C00B56BB2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_60_41924=[""].join("\n");
var outline_f40_60_41924=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13688779\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152592\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11263350\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017293\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017292\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017297\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017298\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017300\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017295\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017296\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017301\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017302\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?39/49/40727?source=related_link\">",
"      Clobazam: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?32/4/32839?source=related_link\">",
"      Clobazam: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_60_41925="Malignant mesothelioma I CT";
var content_f40_60_41925=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F52053%7EPULM%2F70651&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F52053%7EPULM%2F70651&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Malignant mesothelioma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 323px; height: 309px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    CT scan shows right sided nodular circumferential pleural thickening exceeding 1 cm in thickness, typical of a malignant process (arrows). No clear cut invasion of the chest wall is present. A slightly enlarged pretracheal lymph node proved to be reactive in nature.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Malignant mesothelioma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 321px; height: 318px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    CT scan shows right sided circumferential pleural thickening with thickening of the major fissure; there is extension into azygo-esophageal recess and into the anterior mediastinal, pericardial fat.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_60_41925=[""].join("\n");
var outline_f40_60_41925=null;
var title_f40_60_41926="Repair of through and through lip laceration";
var content_f40_60_41926=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F65733&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F65733&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Repair of through and through lip laceration",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 296px; height: 716px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Note: Closure of muscle layer (orbicularis oris) not shown in diagram.",
"    <br>",
"     (A) Opposition of vermilion border.",
"     <br>",
"      (B) Closure of the inner dermal-fat junction.",
"      <br>",
"       (C) Closure of the outer dermal-fat junction.",
"       <br>",
"        (D) Closure of the epidermal layer, with joining of the dermal-fat junction at the free wound edge.",
"        <div class=\"footnotes\">",
"        </div>",
"        <div class=\"reference\">",
"         Reproduced with permission from: Attia MW, Loiselle J. Management of soft-tissue injuries of the mouth. In: Textbook of Pediatric Emergency Procedures, 2nd Edition, King C, Henretig FM (Eds), Lippincott Williams &amp; Wilkins, Philadelphia, 2008. Copyright &copy; 2008 Lippincott Williams &amp; Wilkins.",
"        </div>",
"        <div class=\"contractual\">",
"         <br/>",
"         <a href=\"file://www.lww.com\">",
"          file://www.lww.com",
"         </a>",
"        </div>",
"       </br>",
"      </br>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_60_41926=[""].join("\n");
var outline_f40_60_41926=null;
var title_f40_60_41927="Myopericarditis";
var content_f40_60_41927=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Myopericarditis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/60/41927/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/60/41927/contributors\">",
"     Massimo Imazio, MD, FESC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/60/41927/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/60/41927/contributors\">",
"     Bernard J Gersh, MB, ChB, DPhil, FRCP, MACC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/60/41927/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/60/41927/contributors\">",
"     Brian C Downey, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?40/60/41927/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 10, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pericardium is a fibroelastic sac made up of visceral and parietal layers separated by a (potential) space, the pericardial cavity. In healthy individuals, the pericardial cavity contains 15 to 50 mL of an ultrafiltrate of plasma.",
"   </p>",
"   <p>",
"    Diseases of the pericardium present clinically in one of four ways:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Acute and recurrent pericarditis",
"     </li>",
"     <li>",
"      Pericardial effusion without major hemodynamic compromise",
"     </li>",
"     <li>",
"      Cardiac tamponade",
"     </li>",
"     <li>",
"      Constrictive pericarditis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Acute pericarditis refers to inflammation of the pericardial sac. The term myopericarditis, or perimyocarditis, is used for cases of acute pericarditis that also demonstrate myocardial inflammation. Acute pericarditis and myocarditis often occur together although they are rarely of equivalent intensity. When both are present, they generally give rise to clinical syndromes that are mainly pericarditic or myocarditic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41927/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The term myopericarditis indicates a primarily pericarditic syndrome with minor myocardial involvement, which describes the majority of combined pericarditis and myocarditis cases encountered in clinical practice (",
"    <a class=\"graphic graphic_waveform graphicRef79140 \" href=\"mobipreview.htm?14/6/14439\">",
"     waveform 1",
"    </a>",
"    ). On the other hand, the term perimyocarditis indicates a primarily myocarditic syndrome. However, these two terms are often used interchangeably without regard to the predominant type of cardiac involvement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41927/abstract/2-4\">",
"     2-4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The clinical presentation, diagnostic evaluation, and treatment for myopericarditis will be reviewed here. The etiology of pericarditis, treatment and prognosis of acute pericarditis, and other pericardial disease processes are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/43/30392?source=see_link\">",
"     \"Etiology of pericardial disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/47/37625?source=see_link\">",
"     \"Clinical presentation and diagnostic evaluation of acute pericarditis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/44/713?source=see_link\">",
"     \"Treatment of acute pericarditis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/58/11177?source=see_link\">",
"     \"Recurrent pericarditis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/12/12490?source=see_link\">",
"     \"Constrictive pericarditis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute pericarditis and myocarditis share similar etiologic agents (",
"    <a class=\"graphic graphic_table graphicRef56995 \" href=\"mobipreview.htm?35/10/36014\">",
"     table 1",
"    </a>",
"    ). Limited clinical data on the causes of myopericarditis suggest that viral infections are among the most common causes in developed countries [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41927/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. The most frequent viruses encountered in Western Europe and North America include coxsackieviruses (especially Coxsackie B), adenoviruses, cytomegalovirus, echovirus, influenza virus, Epstein Barr virus, hepatitis C virus, and parvovirus B19.",
"   </p>",
"   <p>",
"    Cardiotropic viruses can cause pericardial and myocardial inflammation via direct cytolytic or cytotoxic effects [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41927/abstract/5-7\">",
"     5-7",
"    </a>",
"    ]. Viral-induced myocyte damage may lead to the release of intracellular proteins that trigger immunopathic responses in the presence of a predisposing genetic background. This mechanism may cause ongoing post-viral myopericardial damage even in the absence of residual viral genome. Similar mechanisms may play a role in other causes of myopericarditis, such as connective tissue diseases, inflammatory bowel disease, and radiation-induced and drug-induced disease.",
"   </p>",
"   <p>",
"    Myopericarditis is not uncommon in patients with inflammatory bowel diseases and among those exposed to radiation or certain drugs. Bacterial and other non-viral infections appear to be rare causes of myopericardial disease. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/21/34137?source=see_link\">",
"     \"Cardiotoxicity of radiation therapy for malignancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Issues related to vaccinia-associated disease are discussed below. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Vaccinia-associated myopericarditis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4339851\">",
"    <span class=\"h2\">",
"     Symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical presentation of myopericarditis reflects the degree of myopericardial involvement, which may be focal or diffuse, affecting one or more cardiac chambers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41927/abstract/8\">",
"     8",
"    </a>",
"    ]. Many cases of myopericarditis are subclinical. In other patients, cardiac symptoms and signs are overshadowed by systemic manifestations of infection or inflammation, such as fever, myalgias, and gastrointestinal symptoms.",
"   </p>",
"   <p>",
"    Among patients who are symptomatic, the manifestations include those associated with pericarditis",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    myocarditis (",
"    <a class=\"graphic graphic_table graphicRef74376 \" href=\"mobipreview.htm?28/1/28700\">",
"     table 2",
"    </a>",
"    ). Patients may complain of positional or pleuritic chest pain with or without fatigue, decreased exercise capacity, dyspnea, or palpitations. Chest pain can occasionally be difficult to distinguish from ischemic pain, particularly since signs of myocardial involvement can simulate an acute coronary syndrome as reported in acute myocarditis. The manifestations of pericarditis and myocarditis are discussed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/47/37625?source=see_link\">",
"     \"Clinical presentation and diagnostic evaluation of acute pericarditis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/16/26889?source=see_link\">",
"     \"Clinical manifestations and diagnosis of myocarditis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Electrocardiogram findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Changes on the surface electrocardiogram (ECG) are common in myopericarditis; these changes reflect some degree of epicardial or myocardial involvement since the parietal pericardium is electrically silent.",
"   </p>",
"   <p>",
"    A typical pattern of ECG evolution commonly occurs in both myopericarditis and acute pericarditis (",
"    <a class=\"graphic graphic_waveform graphicRef79140 \" href=\"mobipreview.htm?14/6/14439\">",
"     waveform 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_waveform graphicRef77572 \" href=\"mobipreview.htm?42/53/43866\">",
"     waveform 2",
"    </a>",
"    ). This pattern includes diffuse ST elevation and PR depression, followed by normalization of ST and PR segments, and then diffuse T wave inversions. The ECG differential diagnosis of both myopericarditis and acute pericarditis includes acute coronary syndrome and early repolarization. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/47/37625?source=see_link&amp;anchor=H2297355#H2297355\">",
"     \"Clinical presentation and diagnostic evaluation of acute pericarditis\", section on 'Electrocardiogram'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/46/35558?source=see_link&amp;anchor=H2#H2\">",
"     \"ECG tutorial: Miscellaneous diagnoses\", section on 'Early repolarization'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Certain ECG features are more common in myopericarditis than in acute pericarditis alone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41927/abstract/3,4,9\">",
"     3,4,9",
"    </a>",
"    ]. In a series of 274 with acute pericarditis, 40 had myopericarditis as defined by serum troponin I elevation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41927/abstract/3\">",
"     3",
"    </a>",
"    ]. The following findings occurred significantly more often in the patients with myopericarditis:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Atypical ECG changes characterized by localized ST-elevation (inferolateral or anterolateral) and T-wave inversion before ST-segment normalization (42 versus 21 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/60/41927/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Cardiac arrhythmias (65 versus 17 percent) including supraventricular or ventricular ectopic beats, as well as nonsustained ventricular tachycardia.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The evaluation of patients with suspected myopericarditis (",
"    <a class=\"graphic graphic_table graphicRef74376 \" href=\"mobipreview.htm?28/1/28700\">",
"     table 2",
"    </a>",
"    ) should include a history and physical examination with particular focus upon symptoms or signs of pericarditis",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    heart failure, cardiac biomarkers, 12-lead ECG, chest radiograph, and transthoracic echocardiogram in all patients. Cardiovascular magnetic resonance (CMR) imaging is mandatory to have a non-invasive confirmation of the clinical diagnosis, while endomyocardial biopsy is helpful for confirming the diagnosis in selected patients where the diagnosis remains uncertain or in patients in whom a specific tissue diagnosis would alter therapy (eg, giant cell myocarditis).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Diagnostic criteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute pericarditis is diagnosed by the presence of two or more of the following features: chest pain, pericardial friction rub, ECG changes (diffuse ST segment elevation or PR depression), and pericardial effusion (",
"    <a class=\"graphic graphic_table graphicRef74376 \" href=\"mobipreview.htm?28/1/28700\">",
"     table 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/47/37625?source=see_link&amp;anchor=H3#H3\">",
"     \"Clinical presentation and diagnostic evaluation of acute pericarditis\", section on 'Clinical presentation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    When acute pericarditis is present, myopericarditis has been diagnosed by the detection of one or both of the following in the absence of evidence of another cause [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41927/abstract/4,10-12\">",
"     4,10-12",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Elevation in serum cardiac biomarkers, such as cardiac troponin I or T (cTnI or cTnT) (see",
"      <a class=\"local\" href=\"#H9\">",
"       'Laboratory studies'",
"      </a>",
"      below)",
"     </li>",
"     <li>",
"      New or presumed new focal or global left ventricular systolic dysfunction on imaging studies",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Hospitalization is recommended for diagnosis and monitoring in patients with myocardial involvement. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/47/37625?source=see_link&amp;anchor=H19#H19\">",
"     \"Clinical presentation and diagnostic evaluation of acute pericarditis\", section on 'Determination of risk and need for hospitalization'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Biomarker elevation appears to be more common than new left ventricular systolic dysfunction, although data are limited [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41927/abstract/3\">",
"     3",
"    </a>",
"    ]. Many clinicians consider an elevation in cardiac biomarkers to be sufficient to diagnose myopericarditis in patients with acute pericarditis. However, biomarker elevations may not be present in all patients with myopericarditis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4340117\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC EVALUATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4340126\">",
"    <span class=\"h2\">",
"     12-lead ECG",
"    </span>",
"    &nbsp;&mdash;&nbsp;A 12-lead electrocardiogram (ECG) should be performed in all patients with suspected myopericarditis. The ECG findings which suggest myopericarditis are discussed above. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Electrocardiogram findings'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Laboratory studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;White blood cell count, erythrocyte sedimentation rate, serum C-reactive protein concentration, and cardiac biomarkers should be checked in all patients with suspected myopericarditis.",
"   </p>",
"   <p>",
"    Laboratory signs of inflammation are common in patients with myopericarditis. These include elevations in white blood cell count, erythrocyte sedimentation rate, and serum C-reactive protein concentration.",
"   </p>",
"   <p>",
"    Biomarker elevation is present in a substantial minority of patients presenting with acute pericarditis. In series of patients with acute idiopathic or viral pericarditis, serum cardiac troponin I (cTnI) &ge;1.5",
"    <span class=\"nowrap\">",
"     microg/L",
"    </span>",
"    was detected in 8 to 22 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41927/abstract/3,9,13\">",
"     3,9,13",
"    </a>",
"    ]. Coronary angiography was performed in most patients with serum cTnI &ge;1.5",
"    <span class=\"nowrap\">",
"     microg/L",
"    </span>",
"    and was normal in all.",
"   </p>",
"   <p>",
"    The elevation in serum cTnI provides a rough estimate of the extent of myocardial inflammation, and typically resolves within 7 to 10 days after presentation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41927/abstract/9\">",
"     9",
"    </a>",
"    ]. Mild increases in serum cTnI often occur in the absence of elevations in CK-MB. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/16/26889?source=see_link\">",
"     \"Clinical manifestations and diagnosis of myocarditis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In a minority of cases (&lt;5 percent) persistent mild increases in serum cTnI for several weeks may reflect ongoing myocardial damage. These patients are generally symptomatic (chest pain, decreased exercise capacity, palpitations). At present there is no evidence that persistent troponin elevation confers worse prognosis in patients with preserved left ventricular function. Usual complete remission is seen in 3 to 6 months.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4340193\">",
"    <span class=\"h2\">",
"     Cardiac imaging studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;All patients with suspected myopericarditis should be evaluated with a chest radiograph and transthoracic echocardiogram. Additional imaging with cardiac magnetic resonance imaging is mandatory to have a non-invasive confirmation of the clinical diagnosis of myocardial inflammatory involvement and especially to rule out a pattern of myocardial infarction (MI) necrosis. In selected patients with coronary risk factors or when differentiation from MI is needed, coronary angiography may be required to rule out obstructive coronary artery disease and an acute coronary syndrome.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4340201\">",
"    <span class=\"h3\">",
"     Chest radiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;The chest radiograph is typically normal in patients with myopericarditis with minimal or small pericardial effusion and normal ventricular function. An enlarged cardiac silhouette may be detected in patients with substantial pericardial effusion (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef57640 \" href=\"mobipreview.htm?10/56/11136\">",
"     image 1",
"    </a>",
"    ) or significant left ventricular dysfunction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Echocardiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with myopericarditis, echocardiography often provides evidence of pericardial disease",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    ventricular dysfunction. Increased pericardial brightness with minimal pericardial effusion is a nonspecific finding. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/28/27077?source=see_link\">",
"     \"Echocardiographic evaluation of the pericardium\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Echocardiography enables noninvasive detection of impaired left ventricular systolic function, even when asymptomatic. In myopericarditis, as for myocarditis generally, left ventricular dysfunction is generally global, but may be segmental. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/21/11610?source=see_link&amp;anchor=H12#H12\">",
"     \"Noninvasive methods for measurement of left ventricular systolic function\", section on 'Echocardiography'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/16/26889?source=see_link\">",
"     \"Clinical manifestations and diagnosis of myocarditis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Cardiovascular magnetic resonance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cardiovascular magnetic resonance is helpful for identifying and characterizing pericardial and myocardial disease. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/3/34874?source=see_link&amp;anchor=H8#H8\">",
"     \"Clinical utility of cardiovascular magnetic resonance imaging\", section on 'Pericardial disease'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/16/26889?source=see_link&amp;anchor=H20#H20\">",
"     \"Clinical manifestations and diagnosis of myocarditis in adults\", section on 'Cardiovascular magnetic resonance'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Endomyocardial biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Histopathologic confirmation of the presence of myocarditis requires an endomyocardial biopsy, but this is usually not performed in patients with no or mild left ventricular systolic dysfunction and no symptoms of heart failure. Indications for endomyocardial biopsy are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/26/7592?source=see_link\">",
"     \"Endomyocardial biopsy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Limited data are available to guide treatment of myopericarditis. Myopericarditis is generally managed as acute pericarditis (",
"    <a class=\"graphic graphic_table graphicRef56484 \" href=\"mobipreview.htm?40/35/41532\">",
"     table 3",
"    </a>",
"    ) when ventricular function is preserved and there are no significant ventricular arrhythmias [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41927/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/44/713?source=see_link\">",
"     \"Treatment of acute pericarditis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Nonsteroidal antiinflammatory drugs (NSAIDs) are a mainstay of therapy for acute pericarditis, but experimental data suggests that more cautious NSAID use may be warranted in patients with myopericarditis. In animal models of myocardial inflammation, NSAIDs are not beneficial and may even enhance the myocarditic process and increase mortality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41927/abstract/14-16\">",
"     14-16",
"    </a>",
"    ]. Thus, in clinical practice lower antiinflammatory doses should be considered with the main goal being symptom control.",
"   </p>",
"   <p>",
"    Specific therapies apply to certain types of myocarditis and nonspecific measures are also recommended, including activity restriction for at least 3 months and follow-up assessments in 6 to 12 weeks and 6 to 12 months. For competitive sport activities, a longer restriction time of 6 months may be considered. Management of myocarditis is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/39/10874?source=see_link\">",
"     \"Natural history and therapy of myocarditis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Limited data are available on the natural history of myopericarditis. The prognosis for idiopathic and viral cases of myopericarditis is generally good, particularly when clinical manifestations are predominantly pericardial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41927/abstract/3,4,9,17,18\">",
"     3,4,9,17,18",
"    </a>",
"    ]. In a prospective study that compared 234 patients with viral or idiopathic acute pericarditis with 40 patients with myopericarditis, the frequency of complications (including recurrences, cardiac tamponade and constriction) was similar in both groups [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41927/abstract/3\">",
"     3",
"    </a>",
"    ]. At 12 months, echocardiography, electrocardiography, and treadmill testing were normal in 39 of the 40 myopericarditis cases. Complications (ie, recurrences, heart failure, persistent LV dysfunction) appear rare in the setting of myopericarditis with preserved or mildly reduced left ventricular ejection fraction (LVEF 45 percent or greater).",
"   </p>",
"   <p>",
"    When substantial myocardial involvement is present (ie, perimyocarditis), the prognosis depends upon the nature and extent of myocardial disease. The natural history of various types of myocarditis is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/39/10874?source=see_link\">",
"     \"Natural history and therapy of myocarditis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     VACCINIA-ASSOCIATED MYOPERICARDITIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Diagnosis and case definitions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vaccinia-associated \"myopericarditis\" has been defined as myocarditis",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    pericarditis occurring within 30 days after",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/24/18823?source=see_link\">",
"     smallpox vaccination",
"    </a>",
"    in the absence of evidence of another likely cause [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41927/abstract/10\">",
"     10",
"    </a>",
"    ]. In a report of United States military recruits, the following case definitions were used for suspected, probable, and confirmed myocarditis and pericarditis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41927/abstract/11\">",
"     11",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Vaccinia-associated myopericarditis'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Suspected myocarditis required the presence of symptoms (dyspnea, palpitations or chest pain) plus ECG changes or focal or diffuse left ventricular dysfunction of uncertain age.",
"     </li>",
"     <li>",
"      Probable myocarditis required the same findings as suspected plus elevated cardiac biomarkers or new onset left ventricular dysfunction or other imaging consistent with myocarditis (cardiovascular magnetic resonance with gadolinium, gallium-67 scanning, anti-myosin antibody scanning).",
"     </li>",
"     <li>",
"      Confirmed myocarditis required histopathologic evidence of myocarditis by endomyocardial biopsy or autopsy. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Endomyocardial biopsy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Suspected pericarditis required typical chest pain (positional, pleuritic, constant) and no evidence for alternative cause of such pain.",
"     </li>",
"     <li>",
"      Probable pericarditis required the same criteria as suspected plus one or more of the following: pericardial rub on auscultation or ECG with new diffuse ST segment elevations or PR segment depressions or echocardiogram revealing an abnormal pericardial effusion.",
"     </li>",
"     <li>",
"      Confirmed pericarditis required evidence of inflammation in pericardial tissue from surgery or autopsy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Incidence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Estimated incidence rates of myocarditis",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    pericarditis after",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/24/18823?source=see_link\">",
"     smallpox vaccination",
"    </a>",
"    range from 0.01 to 3 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41927/abstract/10,11,19-23\">",
"     10,11,19-23",
"    </a>",
"    ]. In a review from the United States military of over 230,000 primary vaccinees, probable myopericarditis was reported in 18 (0.1 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41927/abstract/10\">",
"     10",
"    </a>",
"    ]. There were no cases of myopericarditis among more than 95,000 vaccinees who were previously vaccinated.",
"   </p>",
"   <p>",
"    The above data in young, fit military populations may underestimate the risk since symptoms may be less likely in such patients and screening of asymptomatic vaccinees was not performed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41927/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. Higher estimates in young military recruits in other studies were based upon identification of asymptomatic transient ECG abnormalities of uncertain clinical significance [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41927/abstract/19,20\">",
"     19,20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Virus has been rarely isolated from patients with vaccinia-associated myopericarditis; as a result, an autoimmune mechanism is thought to be responsible for most cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41927/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other complications of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/24/18823?source=see_link\">",
"     smallpox vaccination",
"    </a>",
"    are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/7/40057?source=see_link&amp;anchor=H14#H14\">",
"     \"Vaccinia virus as the smallpox vaccine\", section on 'Specific complications'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Treatment and prognosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Specific guidelines for the management of vaccinia-associated myopericarditis have been outlined by the Department of Defense Vaccine Healthcare Center [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41927/abstract/11\">",
"     11",
"    </a>",
"    ]. According to this algorithm, most patients should receive symptomatic treatment with analgesics",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    NSAIDs, activity restriction for at least four to six weeks and follow-up assessment in six to twelve weeks and six to 12 months.",
"   </p>",
"   <p>",
"    Most patients with vaccinia-associated myopericarditis have mild disease and recover with few short-term effects. On follow-up, functional status and the ECG and echocardiogram normalize in almost all patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41927/abstract/24\">",
"     24",
"    </a>",
"    ]. However, up to 13 percent describe atypical, non-limiting chest discomfort, and fatalities have rarely been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41927/abstract/11,24\">",
"     11,24",
"    </a>",
"    ]. There are no prospective, long-term follow-up data concerning the risk of late-onset dilated cardiomyopathy.",
"   </p>",
"   <p>",
"    In the few patients with progressive symptoms, a reduced LVEF, or sustained ventricular arrhythmias, endomyocardial biopsy should be considered as a guide to therapy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/26/7592?source=see_link\">",
"     \"Endomyocardial biopsy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If biopsy reveals no active viral infection, the process is likely to be autoimmune and glucocorticoids may be beneficial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41927/abstract/3\">",
"     3",
"    </a>",
"    ]. Active viral infection (as documented by polymerase chain reaction) is a rare finding on endomyocardial biopsy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41927/abstract/11\">",
"     11",
"    </a>",
"    ]. If present,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?6/33/6677?source=see_link\">",
"     vaccinia immune globulin",
"    </a>",
"    (VIG) may be considered, since VIG is effective in the treatment of certain noncardiac complications of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/24/18823?source=see_link\">",
"     smallpox vaccine",
"    </a>",
"    . (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/7/40057?source=see_link&amp;anchor=H26#H26\">",
"     \"Vaccinia virus as the smallpox vaccine\", section on 'Vaccinia immune globulin'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    VIG is available from the Centers for Disease Control (CDC) on a compassionate use basis (404-639-3670) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41927/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, \"The Basics\" and \"Beyond the Basics.\" The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on \"patient info\" and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?37/14/38113?source=see_link\">",
"       \"Patient information: Pericarditis in adults (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute pericarditis and myocarditis share similar etiologic agents (",
"      <a class=\"graphic graphic_table graphicRef56995 \" href=\"mobipreview.htm?35/10/36014\">",
"       table 1",
"      </a>",
"      ). Limited clinical data on the causes of myopericarditis suggest that viral infections are among the most common causes in developed countries. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Etiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The clinical presentation of myopericarditis reflects the degree of myopericardial involvement, which may be focal or diffuse. While many cases of myopericarditis are subclinical, the manifestations include those associated with pericarditis",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      myocarditis (",
"      <a class=\"graphic graphic_table graphicRef74376 \" href=\"mobipreview.htm?28/1/28700\">",
"       table 2",
"      </a>",
"      ), including positional or pleuritic chest pain, fatigue, dyspnea, palpitations, fever, or myalgias. (See",
"      <a class=\"local\" href=\"#H4339851\">",
"       'Symptoms'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A typical pattern of electrocardiogram (ECG) evolution commonly occurs in both myopericarditis and acute pericarditis (",
"      <a class=\"graphic graphic_waveform graphicRef79140 \" href=\"mobipreview.htm?14/6/14439\">",
"       waveform 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_waveform graphicRef77572 \" href=\"mobipreview.htm?42/53/43866\">",
"       waveform 2",
"      </a>",
"      ). This pattern includes diffuse ST elevation and PR depression, followed by normalization of ST and PR segments, and then diffuse T wave inversions. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Electrocardiogram findings'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The evaluation of patients with suspected myopericarditis (",
"      <a class=\"graphic graphic_table graphicRef74376 \" href=\"mobipreview.htm?28/1/28700\">",
"       table 2",
"      </a>",
"      ) should include a history and physical examination with particular focus upon symptoms or signs of pericarditis",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      heart failure, cardiac biomarkers, 12-lead ECG, chest radiograph, and transthoracic echocardiogram in all patients. Cardiovascular magnetic resonance (CMR) imaging and endomyocardial biopsy are sometimes helpful for confirming the diagnosis. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In the absence of significant ventricular dysfunction, management of myopericarditis is similar to that for acute pericarditis (",
"      <a class=\"graphic graphic_table graphicRef56484 \" href=\"mobipreview.htm?40/35/41532\">",
"       table 3",
"      </a>",
"      ). In clinical practice lower antiinflammatory doses should be considered with the main goal being symptom control. Activity restriction should be at least three months. If there is significant ventricular dysfunction",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      significant ventricular arrhythmias, therapeutic considerations for myocarditis would apply. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The prognosis of myopericarditis is generally good, although a possible higher cardiac mortality for myopericarditis has been reported in a single study requiring further confirmation. Complications (ie, recurrences, heart failure, persistent LV dysfunction) appear rare in the setting of myopericarditis with preserved or mildly reduced left ventricular ejection fraction (LVEF 45 percent or greater). (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Prognosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Vaccinia-associated \"myopericarditis\" has been defined as myocarditis",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      pericarditis occurring within 30 days after",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?18/24/18823?source=see_link\">",
"       smallpox vaccination",
"      </a>",
"      in the absence of evidence of another likely cause. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Vaccinia-associated myopericarditis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41927/abstract/1\">",
"      Imazio M, Trinchero R. The spectrum of inflammatory myopericardial diseases. Int J Cardiol 2010; 144:134.",
"     </a>",
"    </li>",
"    <li>",
"     Spodick DH. Myopericarditis/Perimyocarditis. In: The Pericardium, Marcel Dekker, Inc, New York 2001. p.114.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41927/abstract/3\">",
"      Imazio M, Cecchi E, Demichelis B, et al. Myopericarditis versus viral or idiopathic acute pericarditis. Heart 2008; 94:498.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41927/abstract/4\">",
"      Imazio M, Trinchero R. Myopericarditis: Etiology, management, and prognosis. Int J Cardiol 2008; 127:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41927/abstract/5\">",
"      Klingel K, Hohenadl C, Canu A, et al. Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc Natl Acad Sci U S A 1992; 89:314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41927/abstract/6\">",
"      Wessely R, Henke A, Zell R, et al. Low-level expression of a mutant coxsackieviral cDNA induces a myocytopathic effect in culture: an approach to the study of enteroviral persistence in cardiac myocytes. Circulation 1998; 98:450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41927/abstract/7\">",
"      Wessely R, Klingel K, Santana LF, et al. Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy. J Clin Invest 1998; 102:1444.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41927/abstract/8\">",
"      Olinde KD, O'Connell JB. Inflammatory heart disease: pathogenesis, clinical manifestations, and treatment of myocarditis. Annu Rev Med 1994; 45:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41927/abstract/9\">",
"      Imazio M, Demichelis B, Cecchi E, et al. Cardiac troponin I in acute pericarditis. J Am Coll Cardiol 2003; 42:2144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41927/abstract/10\">",
"      Halsell JS, Riddle JR, Atwood JE, et al. Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel. JAMA 2003; 289:3283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41927/abstract/11\">",
"      Cassimatis DC, Atwood JE, Engler RM, et al. Smallpox vaccination and myopericarditis: a clinical review. J Am Coll Cardiol 2004; 43:1503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41927/abstract/12\">",
"      Imazio M, Trinchero R. Triage and management of acute pericarditis. Int J Cardiol 2007; 118:286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41927/abstract/13\">",
"      Bonnefoy E, Godon P, Kirkorian G, et al. Serum cardiac troponin I and ST-segment elevation in patients with acute pericarditis. Eur Heart J 2000; 21:832.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41927/abstract/14\">",
"      Costanzo-Nordin MR, Reap EA, O'Connell JB, et al. A nonsteroid anti-inflammatory drug exacerbates Coxsackie B3 murine myocarditis. J Am Coll Cardiol 1985; 6:1078.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41927/abstract/15\">",
"      Rezkalla S, Khatib G, Khatib R. Coxsackievirus B3 murine myocarditis: deleterious effects of nonsteroidal anti-inflammatory agents. J Lab Clin Med 1986; 107:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41927/abstract/16\">",
"      Khatib R, Reyes MP, Smith FE. Enhancement of Coxsackievirus B3 replication in Vero cells by indomethacin. J Infect Dis 1990; 162:997.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41927/abstract/17\">",
"      Imazio M, Spodick DH, Brucato A, et al. Controversial issues in the management of pericardial diseases. Circulation 2010; 121:916.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41927/abstract/18\">",
"      Machado S, Roubille F, Gahide G, et al. Can troponin elevation predict worse prognosis in patients with acute pericarditis? Ann Cardiol Angeiol (Paris) 2010; 59:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41927/abstract/19\">",
"      Ahlborg B, Linroth K, Nordgren B. ECG-changes without subjective symptoms after smallpox vaccination of military personnel. Acta Med Scand Suppl 1966; 464:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41927/abstract/20\">",
"      Helle EP, Koskenvuo K, Heikkil&auml; J, et al. Myocardial complications of immunisations. Ann Clin Res 1978; 10:280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41927/abstract/21\">",
"      Casey CG, Iskander JK, Roper MH, et al. Adverse events associated with smallpox vaccination in the United States, January-October 2003. JAMA 2005; 294:2734.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41927/abstract/22\">",
"      From the Centers for Disease Control and Prevention. Update: cardiac-related events during the civilian smallpox vaccination program-- United States, 2003. JAMA 2003; 290:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41927/abstract/23\">",
"      Arness MK, Eckart RE, Love SS, et al. Myopericarditis following smallpox vaccination. Am J Epidemiol 2004; 160:642.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41927/abstract/24\">",
"      Eckart RE, Love SS, Atwood JE, et al. Incidence and follow-up of inflammatory cardiac complications after smallpox vaccination. J Am Coll Cardiol 2004; 44:201.",
"     </a>",
"    </li>",
"    <li>",
"     Information about vaccinia immune globulin available at www.bt.cdc.gov/agent/smallpox/vaccination/vig.asp (Accessed on March 07, 2005).",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4930 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-58.240.98.179-9F9DC17642-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_60_41927=[""].join("\n");
var outline_f40_60_41927=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H19\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4339851\">",
"      Symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Electrocardiogram findings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Diagnostic criteria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4340117\">",
"      DIAGNOSTIC EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4340126\">",
"      12-lead ECG",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Laboratory studies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4340193\">",
"      Cardiac imaging studies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4340201\">",
"      - Chest radiography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Echocardiography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Cardiovascular magnetic resonance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Endomyocardial biopsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      VACCINIA-ASSOCIATED MYOPERICARDITIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Diagnosis and case definitions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Incidence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Treatment and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/4930\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/4930|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?10/56/11136\" title=\"diagnostic image 1\">",
"      Chest x-ray of a pericardial effusion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/4930|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?35/10/36014\" title=\"table 1\">",
"      Causes of myocarditis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?28/1/28700\" title=\"table 2\">",
"      Diagnosis criteria pericarditis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?40/35/41532\" title=\"table 3\">",
"      Drug therapy in acute pericarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/4930|Waveform\">",
"      <a href=\"#\" title=\"WAVEFORMS\">",
"       WAVEFORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"mobipreview.htm?14/6/14439\" title=\"waveform 1\">",
"      Pericarditis myocarditis spectrum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"mobipreview.htm?42/53/43866\" title=\"waveform 2\">",
"      ECG in pericarditis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/21/34137?source=related_link\">",
"      Cardiotoxicity of radiation therapy for malignancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/16/26889?source=related_link\">",
"      Clinical manifestations and diagnosis of myocarditis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/47/37625?source=related_link\">",
"      Clinical presentation and diagnostic evaluation of acute pericarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/3/34874?source=related_link\">",
"      Clinical utility of cardiovascular magnetic resonance imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/12/12490?source=related_link\">",
"      Constrictive pericarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/46/35558?source=related_link\">",
"      ECG tutorial: Miscellaneous diagnoses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/28/27077?source=related_link\">",
"      Echocardiographic evaluation of the pericardium",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/26/7592?source=related_link\">",
"      Endomyocardial biopsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/43/30392?source=related_link\">",
"      Etiology of pericardial disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/39/10874?source=related_link\">",
"      Natural history and therapy of myocarditis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/21/11610?source=related_link\">",
"      Noninvasive methods for measurement of left ventricular systolic function",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?37/14/38113?source=related_link\">",
"      Patient information: Pericarditis in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/58/11177?source=related_link\">",
"      Recurrent pericarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/44/713?source=related_link\">",
"      Treatment of acute pericarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/7/40057?source=related_link\">",
"      Vaccinia virus as the smallpox vaccine",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_60_41928="Pathogenesis and prevention of diabetic polyneuropathy";
var content_f40_60_41928=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pathogenesis and prevention of diabetic polyneuropathy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/60/41928/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/60/41928/contributors\">",
"     Eva L Feldman, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/60/41928/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/60/41928/contributors\">",
"     Jeremy M Shefner, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/60/41928/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/60/41928/contributors\">",
"     John F Dashe, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?40/60/41928/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 10, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Involvement of the peripheral and autonomic nervous systems is probably the most common complication of diabetes. The duration and severity of hyperglycemia is an important risk factor for the development of diabetic neuropathy in patients with type 1 or type 2 diabetes.",
"   </p>",
"   <p>",
"    This topic will address the pathogenesis and prevention of diabetic polyneuropathy. Other issues related to diabetic neuropathy are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/34/16934?source=see_link\">",
"     \"Epidemiology and classification of diabetic neuropathy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/7/18551?source=see_link\">",
"     \"Clinical manifestations and diagnosis of diabetic polyneuropathy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/43/12986?source=see_link\">",
"     \"Treatment of diabetic neuropathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MORPHOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Distal symmetric polyneuropathy is the most common form of diabetic neuropathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. The proximate cause is a length-dependent \"dying back\" axonopathy, primarily involving the distal portions of the longest myelinated and unmyelinated sensory axons, with relative sparing of motor axons [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/3-5\">",
"     3-5",
"    </a>",
"    ]. Though distal \"dying back\" is commonly seen, there is also evidence for proximal nerve dysfunction at the sensory ganglia, which may contribute to this phenomenon [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/6\">",
"     6",
"    </a>",
"    ]. In addition, the spinal cord appears to be affected; it is not clear if this is a primary neuropathic involvement of the cord or is due to the diabetes itself [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/7,8\">",
"     7,8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Distal symmetric polyneuropathy is morphologically and functionally indistinguishable from many other \"metabolic\" neuropathies, including uremic neuropathy and alcoholic neuropathy. However, in diabetic polyneuropathy, morphologic abnormalities of the vaso nervorum are present early in the course of the disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/9\">",
"     9",
"    </a>",
"    ], and parallel the severity of the nerve fiber loss [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/10-12\">",
"     10-12",
"    </a>",
"    ]. Thus, the morphologic characteristics of diabetic polyneuropathy are consistent with either a vascular or a metabolic etiology [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Epidemiologic studies have identified the duration and severity of hyperglycemia as major risk factors for the development of diabetic neuropathy in patients with type 1 or type 2 diabetes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/14\">",
"     14",
"    </a>",
"    ]. Later investigations have extended the known risk factors beyond hyperglycemia to include dyslipidemia, hypertension, and smoking [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/15,16\">",
"     15,16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a clinical trial of 427 patients with diabetic neuropathy, triglycerides were significantly elevated in subjects with progression of their neuropathy over a one year period compared with those whose neuropathy remained stable, independent of glucose control, type of diabetes, or administration of insulin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/17\">",
"     17",
"    </a>",
"    ]. These data support the emerging concept that common vascular risk factors are associated with the risk of developing diabetic neuropathy.",
"   </p>",
"   <p>",
"    Further evidence of this association comes from the EURODIAB study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/18\">",
"     18",
"    </a>",
"    ]. Among 1172 participants in EURODIAB with type 1 diabetes and no neuropathy at baseline, a distal symmetric polyneuropathy developed over a mean follow-up of 7.3 years in 276 patients (23.5 percent). In addition to duration of diabetes and glycosylated hemoglobin values, the incidence of neuropathy was significantly associated with increased triglyceride levels, body mass index, smoking, and the presence of hypertension at baseline. Several of these risk factors are markers of insulin resistance. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/11/32954?source=see_link\">",
"     \"The metabolic syndrome (insulin resistance syndrome or syndrome X)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Cardiovascular disease at baseline was associated with double the risk of neuropathy, independent of cardiovascular risk factors. [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/18\">",
"     18",
"    </a>",
"    ]",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In diabetes, a complex array of metabolic, vascular and perhaps hormonal factors shift the balance between nerve fiber damage and nerve fiber repair in favor of the former [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/2,19\">",
"     2,19",
"    </a>",
"    ]. This occurs in a fiber-selective pattern that preferentially affects distal sensory and autonomic fibers, leading to the progressive loss of sensation that underlies the clinical manifestations of diabetic polyneuropathy (",
"    <a class=\"graphic graphic_table graphicRef71576 \" href=\"mobipreview.htm?13/45/14045\">",
"     table 1",
"    </a>",
"    ). Among the ischemic factors, endothelial dysfunction may be especially important, particularly in patients with type 2 diabetes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Metabolic factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mechanism by which lack of glycemic control and cardiovascular factors predisposes to microvascular disease is incompletely understood [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/19\">",
"     19",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/34/11817?source=see_link\">",
"     \"Glycemic control and vascular complications in type 1 diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Implicated metabolic factors include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Accumulation of advanced glycosylation end products",
"     </li>",
"     <li>",
"      Accumulation of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?29/0/29699?source=see_link\">",
"       sorbitol",
"      </a>",
"     </li>",
"     <li>",
"      Disruption of the hexosamine pathway",
"     </li>",
"     <li>",
"      Disruption of the protein kinase C pathway",
"     </li>",
"     <li>",
"      Activation of the poly (ADP-ribose) polymerase pathway",
"     </li>",
"     <li>",
"      Increased oxidative stress",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Advanced glycosylation end products",
"    </span>",
"    &nbsp;&mdash;&nbsp;Glycosylation of plasma and tissue proteins leading to the formation of advanced glycosylation end products plays an important role in diabetic microvascular complications [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. In chronic hyperglycemia, for example, some of the excess glucose combines with amino acids on circulating or tissue proteins. This nonenzymatic process initially forms reversible early glycosylation products and later irreversible advanced glycosylation end products (AGEs) via an Amadori rearrangement (",
"    <a class=\"graphic graphic_figure graphicRef80716 \" href=\"mobipreview.htm?22/4/22606\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Serum AGE concentrations are increased in patients with diabetes. These AGE peptides (molecular weight between 2000 and 6000) have strong cross-linking activity with collagen in vitro, which may play a role in the development of diabetic microvascular complications. AGEs bind to the cell surface receptor called RAGE (receptor for AGE). Activation of RAGE is proinflammatory. Other effects of AGEs that also can contribute to vascular injury include increases in vascular permeability, procoagulant activity, adhesion molecule expression, and monocyte influx [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Sorbitol",
"    </span>",
"    &nbsp;&mdash;&nbsp;Glucose that enters cells is metabolized in part to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?29/0/29699?source=see_link\">",
"     sorbitol",
"    </a>",
"    via the enzyme aldose reductase (",
"    <a class=\"graphic graphic_figure graphicRef81926 \" href=\"mobipreview.htm?7/24/7565\">",
"     figure 2",
"    </a>",
"    ). This process is more pronounced with chronic hyperglycemia. The accumulation of sorbitol within the cells leads to depletion of NADPH, a rise in cell osmolality and a decrease in intracellular myoinositol, all of which interfere with cell metabolism and predispose cells to oxidative stress [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/25\">",
"     25",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/44/13000?source=see_link\">",
"     \"Aldose reductase inhibitors in the prevention of diabetic complications\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Hexosamine",
"    </span>",
"    &nbsp;&mdash;&nbsp;Excess glucose shunts glycolytic intermediates into the hexosamine pathway, producing uridine diphosphate-N-acetyl glucosamine (UDPGlcNAc), a molecule that modifies transcription factors essential for normal cell function. Increased flux through the hexosamine pathway results in cellular damage and enhanced oxidative stress [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/26\">",
"     26",
"    </a>",
"    ]. In men with type 1 diabetes, oral benfotiamine reduces both oxidative stress and hexosamine-modified proteins and has been proposed as a potential therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Protein kinase C",
"    </span>",
"    &nbsp;&mdash;&nbsp;High glucose is converted to diacylglycerol that activates protein kinase C. Protein kinase C activation produces vasoconstriction and nerve hypoxia; these neurovascular changes promote diabetic neuropathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Poly (ADP-ribose) polymerase",
"    </span>",
"    &nbsp;&mdash;&nbsp;The nuclear enzyme poly (ADP-ribose) polymerase (PARP) is activated in response to high glucose. It cleaves nicotinamide adenine dinucleotide (NAD+) to nicotinamide and ADP-ribose residues and assists in repairing DNA. Excess activation of PARP results in increased free radical formation, deleterious changes in gene transcription, enhanced protein kinase C activity, and AGE formation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/29\">",
"     29",
"    </a>",
"    ]. PARP inhibitors are effective in the treatment of experimental diabetic neuropathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Oxidative stress",
"    </span>",
"    &nbsp;&mdash;&nbsp;As outlined above, hyperglycemia impacts multiple metabolic pathways whose end result is oxidative stress and the accumulation of reactive oxygen species (ROS) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/31\">",
"     31",
"    </a>",
"    ]. Oxidative stress provides a unifying mechanism for neural damage and for the onset and progression of diabetic neuropathy. Because different metabolic impairments are tightly interrelated, a vicious feed-forward cycle of altered metabolism, ROS accumulation, and reduced antioxidant defense occurs. This leads to peripheral nerve damage and the signs and symptoms of diabetic neuropathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/19,32-34\">",
"     19,32-34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In support of a role for oxidative stress in the pathogenesis of peripheral neuropathy, patients with diabetes who are treated with antioxidants show clinically meaningful improvements in neuropathic symptoms and neuropathic deficits [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/35-37\">",
"     35-37",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/43/12986?source=see_link\">",
"     \"Treatment of diabetic neuropathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Role of ischemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nerve ischemia has been invoked in the pathogenesis of diabetic polyneuropathy because of the presence of thickened endoneurial blood vessel walls and vascular occlusions at autopsy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/38\">",
"     38",
"    </a>",
"    ]. This is supported by morphological [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/10,11,39-41\">",
"     10,11,39-41",
"    </a>",
"    ] and clinical evidence, including a reduction in endoneurial oxygen tension in the sural nerves of diabetic patients with advanced polyneuropathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Focal rather than diffuse fiber loss has been reported in diabetic polyneuropathy, resembling that occurring after microvascular embolization or vasculitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/43\">",
"     43",
"    </a>",
"    ]; these findings have been disputed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/44\">",
"     44",
"    </a>",
"    ] or described as nonspecific [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/45\">",
"     45",
"    </a>",
"    ]. In addition, small vessel vasculitis is detectable in the nerves of patients with type 2 diabetes and peripheral neuropathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/46\">",
"     46",
"    </a>",
"    ]. However, the striking predilection of diabetes to damage sensory and autonomic fibers is difficult to explain on the basis of focal endoneurial ischemia.",
"   </p>",
"   <p>",
"    These considerations do not exclude an ischemic component to the development of diabetic polyneuropathy, the importance of which is strongly supported by accumulating evidence from animal studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/47-49\">",
"     47-49",
"    </a>",
"    ]. As an example, metabolic interventions (eg, inhibitors of protein kinase C activation) that improve nerve conduction also correct the reduced nerve blood flow in diabetic rats [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/50\">",
"     50",
"    </a>",
"    ]. Furthermore, retrospective studies have found reduced levels of thrombomodulin and tissue plasminogen activator in peripheral nerve microvessels from patients with diabetes, suggesting that an impairment of antithrombotic mechanisms plays a role in the pathogenesis of diabetic polyneuropathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/51,52\">",
"     51,52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Ischemic and metabolic factors may operate together [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/19\">",
"     19",
"    </a>",
"    ]. Ischemia itself has metabolic consequences that may be exacerbated by insulin deficiency and hyperglycemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/53-56\">",
"     53-56",
"    </a>",
"    ]. The exact nature of this vascular-metabolic interaction is unclear, and may be multifactorial (",
"    <a class=\"graphic graphic_table graphicRef71576 \" href=\"mobipreview.htm?13/45/14045\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/19\">",
"     19",
"    </a>",
"    ], with a possible role for inflammation, specifically acute phase reactants and interleukins [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/57\">",
"     57",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Role of nerve fiber repair mechanisms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Peripheral nerve repair is impaired in diabetes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/58,59\">",
"     58,59",
"    </a>",
"    ]. This complication may be due to disease-induced loss of neurotrophic peptides that normally mediate nerve repair, regeneration, and tonic maintenance. These peptides include nerve growth factor, brain-derived neurotrophic factor, neurotrophin-3, the insulin-like growth factors, and vascular endothelial growth factor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/59\">",
"     59",
"    </a>",
"    ]. Additionally, insulin functions as a neurotrophic factor to peripheral neurons, and thus loss of insulin in type 1 diabetes may compromise nerve viability and repair [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Studies in laboratory animals suggest that expression of nerve growth factor and other neurotrophic factors may be decreased in diabetes, which could lead to decreased repair and perhaps impaired maintenance of peripheral nerve fibers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/61\">",
"     61",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Glycemic control",
"    </span>",
"    &nbsp;&mdash;&nbsp;Improved glycemic control improves nerve function in patients with diabetes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/62-65\">",
"     62-65",
"    </a>",
"    ]. In addition, there is good evidence that intensive glycemic control reduces the risk of developing diabetic neuropathy in patients with type 1 diabetes and may reduce the risk in patients with type 2 diabetes. In a 2012 systematic review of randomized controlled trials of glycemic control that reported data for the incidence of clinical neuropathy in those without clinical neuropathy at baseline, the following observations were made [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/66\">",
"     66",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In data from two trials involving 1228 subjects with type 1 diabetes, those assigned to enhanced glycemic control had a significantly reduced incidence of clinical neuropathy at five years (8 versus 17 percent, annualized risk difference -1.84 percent, 95% CI -2.56 to -1.11) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/66\">",
"       66",
"      </a>",
"      ]. The DCCT trial [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/67,68\">",
"       67,68",
"      </a>",
"      ] contributed 97 percent of the subjects with type 1 diabetes to the analysis.",
"     </li>",
"     <li>",
"      In data from four trials involving 6669 subjects with type 2 diabetes, those assigned to enhanced glycemic control had a small reduction in the incidence of clinical neuropathy at final follow-up that did not achieve statistical significance (annualized risk difference -0.58 percent, 95% CI -1.17 to 0.01) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/66\">",
"       66",
"      </a>",
"      ]. The ACCORD trial [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/69\">",
"       69",
"      </a>",
"      ] contributed approximately 71 percent of the subjects to this analysis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The role of glycemic control in the prevention of clinically evident diabetic neuropathy, and in halting its progression, was firmly established for patients with type 1 diabetes by the DCCT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/67,68,70\">",
"     67,68,70",
"    </a>",
"    ]. The DCCT was a multicenter randomized trial that evaluated the effect of intensive versus conventional treatment of patients with type 1 diabetes who did not have advanced diabetic complications. Patients with neuropathy of such severity as to require treatment were excluded from the trial, but patients with abnormal nerve conduction, mild neuropathic symptoms or mild sensory deficits were enrolled. The presence of definite clinical neuropathy was defined by the presence of at least two of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Symptoms consistent with diabetic neuropathy",
"     </li>",
"     <li>",
"      Sensory deficits consistent with diabetic neuropathy",
"     </li>",
"     <li>",
"      Diminished or absent reflexes consistent with diabetic neuropathy",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The presence of only one abnormality classified the patient as having possible diabetic neuropathy. The presence of definite neuropathy (two abnormalities) was confirmed by abnormalities in either nerve conduction (abnormalities in at least two anatomically distinct nerves) or cardiovascular autonomic function tests (beat-to-beat heart rate variability or Valsalva ratio).",
"   </p>",
"   <p>",
"    At baseline, the patients were stratified into two cohorts based upon the absence (\"primary prevention cohort\") or the presence (\"secondary intervention cohort\") of background diabetic retinopathy (preproliferative or proliferative retinopathy was an exclusion). Patients in each cohort were evaluated for neuropathy at baseline and randomly assigned to conventional (one to two insulin",
"    <span class=\"nowrap\">",
"     injections/day)",
"    </span>",
"    or intensive (three or more insulin",
"    <span class=\"nowrap\">",
"     injections/day",
"    </span>",
"    with frequent blood glucose monitoring and follow-up) treatment.",
"   </p>",
"   <p>",
"    Neuropathy was reassessed after five years. Intensive insulin treatment, which resulted in hemoglobin A1C values approximately 2 percent lower than conventional treatment, was associated with a 60 to 70 percent reduction in the risk for developing definite neuropathy in patients who did not have it at baseline (",
"    <a class=\"graphic graphic_figure graphicRef70914 graphicRef50952 \" href=\"mobipreview.htm?12/40/12943\">",
"     figure 3A-B",
"    </a>",
"    ). This reduction in the development of definite clinical neuropathy was expressed in all three components of this disorder, ie, the clinical examination, nerve conduction studies, and autonomic nerve studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The incidence of clinical neuropathy (defined as suggestive findings from the history and physical examination that were confirmed by neurologic testing) was reduced with intensive insulin therapy by 64 percent in the group as a whole (5 versus 13 percent) and 67 percent in the primary prevention cohort (3 versus 10 percent).",
"     </li>",
"     <li>",
"      Intensive insulin therapy also reduced the incidence of abnormal nerve conduction by 44 percent (26 versus 46 percent) and of autonomic dysfunction by 53 percent (4 versus 9 nine percent).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Intensive insulin therapy, when initiated early, appears to provide a durable benefit for the prevention of clinically evident neuropathy. The EDIC study followed about 95 percent of subjects in the DCCT cohort after the conclusion of the DCCT study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/71\">",
"     71",
"    </a>",
"    ]. Subjects who had been in the intensive insulin group of the DCCT were encouraged to maintain intensive therapy, and subjects who had been in the conventional group were encouraged to begin intensive therapy. Despite a narrowing and disappearance of prior glycemic separation, the difference in the prevalence of neuropathy between the DCCT treatment groups persisted over eight years of EDIC follow-up. Prior intensive insulin therapy in the DCCT reduced the odds of neuropathic symptoms and neuropathic signs by 51 and 43 percent, respectively.",
"   </p>",
"   <p>",
"    These data clearly establish that improved metabolic control markedly reduces the risk of developing diabetic neuropathy, both somatic and autonomic, in patients with type 1 diabetes. The Oslo study suggested that there was a graded effect of hyperglycemia on disease progression because each 1 percent rise in hemoglobin A1C values was associated with a 1.3",
"    <span class=\"nowrap\">",
"     m/sec",
"    </span>",
"    slowing of nerve conduction at eight years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/72\">",
"     72",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Furthermore, these and other observations suggest, but do not prove, that improved metabolic control would have equally potent effects on the prevention of diabetic neuropathy in patients with type 2 diabetes.",
"   </p>",
"   <p>",
"    While not as robust, findings from the UKPDS trial support the idea that glycemic control may be important in the prevention of diabetic neuropathy in patients with type 2 diabetes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/73\">",
"     73",
"    </a>",
"    ]. In the UKPDS, 3867 patients with newly diagnosed type 2 diabetes received either intensive treatment (insulin or an oral agent) or conventional treatment with diet. After 10 years, patients on intensive treatment had a 25 percent risk reduction in microvascular complications (ie, retinopathy and nephropathy). Most of this reduction was driven by the retinopathy endpoint. Trends, but not statistically significant differences, were present in neuropathic endpoints at year 10. However, at year 15, sensory perception in the legs was significantly preserved by intensive versus conventional treatment, with neuropathy present in 31.2 versus 51.7 percent (relative risk reduction 60 percent, 95% CI 0.39-0.94), although this was in a smaller cohort of less than 250 patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Vascular risk factor treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The association of vascular risk factors with diabetic neuropathy (see",
"    <a class=\"local\" href=\"#H3\">",
"     'Risk factors'",
"    </a>",
"    above) suggests that treating dyslipidemia and hypertension and other cardiovascular risk factors could slow or prevent the progression of diabetic neuropathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/74\">",
"     74",
"    </a>",
"    ]. However, there are no clinical trial data that address this issue.",
"   </p>",
"   <p>",
"    Nonetheless, recommendations for prevention of other complications of diabetes include improved control of blood pressure, lipids, avoidance of cigarette smoking, and avoidance of excess alcohol consumption [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41928/abstract/75\">",
"     75",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?19/47/20208?source=see_link\">",
"       \"Patient information: Nerve damage caused by diabetes (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?21/5/21587?source=see_link\">",
"       \"Patient information: Diabetic neuropathy (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H185172517\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Distal symmetric polyneuropathy is the most common form of diabetic neuropathy. The proximate cause is a length-dependent \"dying back\" axonopathy, primarily involving the distal portions of the longest myelinated and unmyelinated sensory axons, with relative sparing of motor axons. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Morphology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The duration and severity of hyperglycemia are major risk factors for the development of diabetic neuropathy in patients with type 1 or type 2 diabetes. Additional risk factors include dyslipidemia, hypertension, and smoking. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In diabetes, a complex array of metabolic, vascular, and perhaps hormonal factors shift the balance between nerve fiber damage and nerve fiber repair in favor of the former. This occurs in a fiber-selective pattern that preferentially affects distal sensory and autonomic fibers, leading to the progressive loss of sensation that underlies the clinical manifestations of diabetic polyneuropathy (",
"      <a class=\"graphic graphic_table graphicRef71576 \" href=\"mobipreview.htm?13/45/14045\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Nerve ischemia has been invoked in the pathogenesis of diabetic polyneuropathy because of the presence of thickened endoneurial blood vessel walls and vascular occlusions at autopsy. This is supported by morphological and clinical evidence. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Role of ischemia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Improved metabolic control markedly reduces the risk of developing diabetic neuropathy in patients with type 1 diabetes and may be useful for the prevention of diabetic neuropathy in patients with type 2 diabetes. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Glycemic control'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/1\">",
"      Dyck PJ, Kratz KM, Karnes JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993; 43:817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/2\">",
"      Callaghan BC, Cheng HT, Stables CL, et al. Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol 2012; 11:521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/3\">",
"      Malik RA. The pathology of human diabetic neuropathy. Diabetes 1997; 46 Suppl 2:S50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/4\">",
"      Malik RA, Veves A, Walker D, et al. Sural nerve fibre pathology in diabetic patients with mild neuropathy: relationship to pain, quantitative sensory testing and peripheral nerve electrophysiology. Acta Neuropathol 2001; 101:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/5\">",
"      Kles KA, Vinik AI. Pathophysiology and treatment of diabetic peripheral neuropathy: the case for diabetic neurovascular function as an essential component. Curr Diabetes Rev 2006; 2:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/6\">",
"      Toth C, Brussee V, Cheng C, Zochodne DW. Diabetes mellitus and the sensory neuron. J Neuropathol Exp Neurol 2004; 63:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/7\">",
"      Eaton SE, Harris ND, Rajbhandari SM, et al. Spinal-cord involvement in diabetic peripheral neuropathy. Lancet 2001; 358:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/8\">",
"      Selvarajah D, Wilkinson ID, Emery CJ, et al. Early involvement of the spinal cord in diabetic peripheral neuropathy. Diabetes Care 2006; 29:2664.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/9\">",
"      Malik RA, Tesfaye S, Newrick PG, et al. Sural nerve pathology in diabetic patients with minimal but progressive neuropathy. Diabetologia 2005; 48:578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/10\">",
"      Dyck PJ, Hansen S, Karnes J, et al. Capillary number and percentage closed in human diabetic sural nerve. Proc Natl Acad Sci U S A 1985; 82:2513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/11\">",
"      Dyck PJ, Karnes JL, O'Brien P, et al. The spatial distribution of fiber loss in diabetic polyneuropathy suggests ischemia. Ann Neurol 1986; 19:440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/12\">",
"      Pf&uuml;tzner A, Forst T, Engelbach M, et al. The influence of isolated small nerve fibre dysfunction on microvascular control in patients with diabetes mellitus. Diabet Med 2001; 18:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/13\">",
"      Cameron NE, Eaton SE, Cotter MA, Tesfaye S. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia 2001; 44:1973.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/14\">",
"      Genuth S. Insights from the diabetes control and complications trial/epidemiology of diabetes interventions and complications study on the use of intensive glycemic treatment to reduce the risk of complications of type 1 diabetes. Endocr Pract 2006; 12 Suppl 1:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/15\">",
"      Dyck PJ, Davies JL, Wilson DM, et al. Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetes Care 1999; 22:1479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/16\">",
"      Hanssen KF. Blood glucose control and microvascular and macrovascular complications in diabetes. Diabetes 1997; 46 Suppl 2:S101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/17\">",
"      Wiggin TD, Sullivan KA, Pop-Busui R, et al. Elevated triglycerides correlate with progression of diabetic neuropathy. Diabetes 2009; 58:1634.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/18\">",
"      Tesfaye S, Chaturvedi N, Eaton SE, et al. Vascular risk factors and diabetic neuropathy. N Engl J Med 2005; 352:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/19\">",
"      Edwards JL, Vincent AM, Cheng HT, Feldman EL. Diabetic neuropathy: mechanisms to management. Pharmacol Ther 2008; 120:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/20\">",
"      Kilo S, Berghoff M, Hilz M, Freeman R. Neural and endothelial control of the microcirculation in diabetic peripheral neuropathy. Neurology 2000; 54:1246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/21\">",
"      Thornalley PJ. Glycation in diabetic neuropathy: characteristics, consequences, causes, and therapeutic options. Int Rev Neurobiol 2002; 50:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/22\">",
"      Sugimoto K, Yasujima M, Yagihashi S. Role of advanced glycation end products in diabetic neuropathy. Curr Pharm Des 2008; 14:953.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/23\">",
"      Ahmed N, Thornalley PJ. Advanced glycation endproducts: what is their relevance to diabetic complications? Diabetes Obes Metab 2007; 9:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/24\">",
"      Singh R, Barden A, Mori T, Beilin L. Advanced glycation end-products: a review. Diabetologia 2001; 44:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/25\">",
"      Oates PJ. Aldose reductase, still a compelling target for diabetic neuropathy. Curr Drug Targets 2008; 9:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/26\">",
"      Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414:813.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/27\">",
"      Du X, Edelstein D, Brownlee M. Oral benfotiamine plus alpha-lipoic acid normalises complication-causing pathways in type 1 diabetes. Diabetologia 2008; 51:1930.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/28\">",
"      Das Evcimen N, King GL. The role of protein kinase C activation and the vascular complications of diabetes. Pharmacol Res 2007; 55:498.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/29\">",
"      Pacher P, Obrosova IG, Mabley JG, Szab&oacute; C. Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies. Curr Med Chem 2005; 12:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/30\">",
"      Li F, Drel VR, Szab&oacute; C, et al. Low-dose poly(ADP-ribose) polymerase inhibitor-containing combination therapies reverse early peripheral diabetic neuropathy. Diabetes 2005; 54:1514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/31\">",
"      Pop-Busui R, Sima A, Stevens M. Diabetic neuropathy and oxidative stress. Diabetes Metab Res Rev 2006; 22:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/32\">",
"      Vincent AM, McLean LL, Backus C, Feldman EL. Short-term hyperglycemia produces oxidative damage and apoptosis in neurons. FASEB J 2005; 19:638.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/33\">",
"      Schmeichel AM, Schmelzer JD, Low PA. Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy. Diabetes 2003; 52:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/34\">",
"      Vincent AM, Russell JW, Low P, Feldman EL. Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr Rev 2004; 25:612.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/35\">",
"      Ziegler D, Nowak H, Kempler P, et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabet Med 2004; 21:114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/36\">",
"      Ametov AS, Barinov A, Dyck PJ, et al. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial. Diabetes Care 2003; 26:770.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/37\">",
"      Ziegler D, Ametov A, Barinov A, et al. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care 2006; 29:2365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/38\">",
"      FAGERBERG SE. Diabetic neuropathy: a clinical and histological study on the significance of vascular affections. Acta Med Scand Suppl 1959; 345:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/39\">",
"      Dyck PJ, Lais A, Karnes JL, et al. Fiber loss is primary and multifocal in sural nerves in diabetic polyneuropathy. Ann Neurol 1986; 19:425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/40\">",
"      Vracko R. A comparison of the microvascular lesions in diabetes mellitus with those in normal aging. J Am Geriatr Soc 1982; 30:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/41\">",
"      Williams E, Timperley WR, Ward JD, Duckworth T. Electron microscopical studies of vessels in diabetic peripheral neuropathy. J Clin Pathol 1980; 33:462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/42\">",
"      Newrick PG, Wilson AJ, Jakubowski J, et al. Sural nerve oxygen tension in diabetes. Br Med J (Clin Res Ed) 1986; 293:1053.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/43\">",
"      Nukada H, Dyck PJ. Microsphere embolization of nerve capillaries and fiber degeneration. Am J Pathol 1984; 115:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/44\">",
"      Sima AA, Nathaniel V, Prashar A, et al. Endoneurial microvessels in human diabetic neuropathy. Endothelial cell dysjunction and lack of treatment effect by aldose reductase inhibitor. Diabetes 1991; 40:1090.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/45\">",
"      Llewelyn JG, Thomas PK, Gilbey SG, et al. Pattern of myelinated fibre loss in the sural nerve in neuropathy related to type 1 (insulin-dependent) diabetes. Diabetologia 1988; 31:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/46\">",
"      Kelkar P, Masood M, Parry GJ. Distinctive pathologic findings in proximal diabetic neuropathy (diabetic amyotrophy). Neurology 2000; 55:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/47\">",
"      Zochodne DW, Cheng C, Sun H. Diabetes increases sciatic nerve susceptibility to endothelin-induced ischemia. Diabetes 1996; 45:627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/48\">",
"      Salis MB, Graiani G, Desortes E, et al. Nerve growth factor supplementation reverses the impairment, induced by Type 1 diabetes, of hindlimb post-ischaemic recovery in mice. Diabetologia 2004; 47:1055.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/49\">",
"      Wang Y, Schmeichel AM, Iida H, et al. Ischemia-reperfusion injury causes oxidative stress and apoptosis of Schwann cell in acute and chronic experimental diabetic neuropathy. Antioxid Redox Signal 2005; 7:1513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/50\">",
"      Cotter MA, Jack AM, Cameron NE. Effects of the protein kinase C beta inhibitor LY333531 on neural and vascular function in rats with streptozotocin-induced diabetes. Clin Sci (Lond) 2002; 103:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/51\">",
"      Hafer-Macko CE, Ivey FM, Gyure KA, et al. Thrombomodulin deficiency in human diabetic nerve microvasculature. Diabetes 2002; 51:1957.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/52\">",
"      Hafer-Macko CE, Ivey FM, Sorkin JD, Macko RF. Microvascular tissue plasminogen activator is reduced in diabetic neuropathy. Neurology 2007; 69:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/53\">",
"      Karasu C, Dewhurst M, Stevens EJ, Tomlinson DR. Effects of anti-oxidant treatment on sciatic nerve dysfunction in streptozotocin-diabetic rats; comparison with essential fatty acids. Diabetologia 1995; 38:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/54\">",
"      Cameron NE, Cotter MA, Ferguson K, et al. Effects of chronic alpha-adrenergic receptor blockade on peripheral nerve conduction, hypoxic resistance, polyols, Na(+)-K(+)-ATPase activity, and vascular supply in STZ-D rats. Diabetes 1991; 40:1652.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/55\">",
"      Cameron NE, Cotter MA, Robertson S. Essential fatty acid diet supplementation. Effects on peripheral nerve and skeletal muscle function and capillarization in streptozocin-induced diabetic rats. Diabetes 1991; 40:532.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/56\">",
"      Pieper GM, Gross GJ. Oxygen free radicals abolish endothelium-dependent relaxation in diabetic rat aorta. Am J Physiol 1988; 255:H825.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/57\">",
"      Herder C, Lankisch M, Ziegler D, et al. Subclinical inflammation and diabetic polyneuropathy: MONICA/KORA Survey F3 (Augsburg, Germany). Diabetes Care 2009; 32:680.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/58\">",
"      Kennedy JM, Zochodne DW. The regenerative deficit of peripheral nerves in experimental diabetes: its extent, timing and possible mechanisms. Brain 2000; 123 ( Pt 10):2118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/59\">",
"      Kennedy JM, Zochodne DW. Impaired peripheral nerve regeneration in diabetes mellitus. J Peripher Nerv Syst 2005; 10:144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/60\">",
"      Brussee V, Cunningham FA, Zochodne DW. Direct insulin signaling of neurons reverses diabetic neuropathy. Diabetes 2004; 53:1824.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/61\">",
"      Leinninger GM, Vincent AM, Feldman EL. The role of growth factors in diabetic peripheral neuropathy. J Peripher Nerv Syst 2004; 9:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/62\">",
"      Graf RJ, Halter JB, Pfeifer MA, et al. Glycemic control and nerve conduction abnormalities in non-insulin-dependent diabetic subjects. Ann Intern Med 1981; 94:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/63\">",
"      Holman RR, Dornan TL, Mayon-White V, et al. Prevention of deterioration of renal and sensory-nerve function by more intensive management of insulin-dependent diabetic patients. A two-year randomised prospective study. Lancet 1983; 1:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/64\">",
"      Pietri A, Ehle AL, Raskin P. Changes in nerve conduction velocity after six weeks of glucoregulation with portable insulin infusion pumps. Diabetes 1980; 29:668.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/65\">",
"      Kuwabara S, Ogawara K, Harrori T, et al. The acute effects of glycemic control on axonal excitability in human diabetic nerves. Intern Med 2002; 41:360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/66\">",
"      Callaghan BC, Little AA, Feldman EL, Hughes RA. Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database Syst Rev 2012; 6:CD007543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/67\">",
"      The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329:977.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/68\">",
"      Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and Complications Trial. Ann Neurol 1995; 38:869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/69\">",
"      Ismail-Beigi F, Craven T, Banerji MA, et al. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet 2010; 376:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/70\">",
"      The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research Group. Ann Intern Med 1995; 122:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/71\">",
"      Martin CL, Albers J, Herman WH, et al. Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion. Diabetes Care 2006; 29:340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/72\">",
"      Amthor KF, Dahl-J&oslash;rgensen K, Berg TJ, et al. The effect of 8 years of strict glycaemic control on peripheral nerve function in IDDM patients: the Oslo Study. Diabetologia 1994; 37:579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/73\">",
"      Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352:837.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/74\">",
"      Perkins BA, Bril V. Early vascular risk factor modification in type 1 diabetes. N Engl J Med 2005; 352:408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41928/abstract/75\">",
"      Boulton AJ, Vinik AI, Arezzo JC, et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 2005; 28:956.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5279 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-61.55.141.10-024AF9ABBA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_60_41928=[""].join("\n");
var outline_f40_60_41928=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H185172517\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MORPHOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Metabolic factors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Advanced glycosylation end products",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Sorbitol",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Hexosamine",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Protein kinase C",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Poly (ADP-ribose) polymerase",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Oxidative stress",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Role of ischemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Role of nerve fiber repair mechanisms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Glycemic control",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Vascular risk factor treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H185172517\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEURO/5279\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/5279|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?22/4/22606\" title=\"figure 1\">",
"      Glycosylation of proteins",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?7/24/7565\" title=\"figure 2\">",
"      Sorbitol pathway in diabetes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?38/56/39821\" title=\"figure 3A\">",
"      Neuropathy and glycemic control I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?3/8/3214\" title=\"figure 3B\">",
"      Neuropathy and glycemic control II",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/5279|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?13/45/14045\" title=\"table 1\">",
"      Pathogenesis diab neuropathy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/44/13000?source=related_link\">",
"      Aldose reductase inhibitors in the prevention of diabetic complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/7/18551?source=related_link\">",
"      Clinical manifestations and diagnosis of diabetic polyneuropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/34/16934?source=related_link\">",
"      Epidemiology and classification of diabetic neuropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/34/11817?source=related_link\">",
"      Glycemic control and vascular complications in type 1 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?21/5/21587?source=related_link\">",
"      Patient information: Diabetic neuropathy (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?19/47/20208?source=related_link\">",
"      Patient information: Nerve damage caused by diabetes (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/11/32954?source=related_link\">",
"      The metabolic syndrome (insulin resistance syndrome or syndrome X)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/43/12986?source=related_link\">",
"      Treatment of diabetic neuropathy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_60_41929="Management of postpartum hemorrhage at vaginal delivery";
var content_f40_60_41929=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Management of postpartum hemorrhage at vaginal delivery",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/60/41929/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/60/41929/contributors\">",
"     Allan J Jacobs, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/60/41929/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/60/41929/contributors\">",
"     Charles J Lockwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/60/41929/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/60/41929/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?40/60/41929/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 8, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The approach to treatment of postpartum hemorrhage (PPH) differs somewhat depending on the cause and whether hemorrhage occurs after a vaginal birth or after a cesarean delivery. Avoidance of laparotomy, when possible, is a goal in patients who have had a vaginal birth, whereas this is not a major consideration at cesarean delivery.",
"   </p>",
"   <p>",
"    This topic will discuss the approach to the patient with PPH after a vaginal delivery. An overview of issues related to diagnosis and management of postpartum hemorrhage and the approach to the patient with PPH after cesarean delivery are reviewed separately:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/38/42600?source=see_link\">",
"       \"Overview of postpartum hemorrhage\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/44/27336?source=see_link\">",
"       \"Management of postpartum hemorrhage at cesarean delivery\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INITIAL INTERVENTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ideally each labor and delivery unit has a postpartum hemorrhage protocol for patients with estimated blood loss exceeding a predefined threshold (often 1000 mL). These protocols provide a standardized approach to evaluating and monitoring the patient, notifying a multidisciplinary team, and treatment. The next several sections provide recommendations including this type of protocol (",
"    <a class=\"graphic graphic_table graphicRef57307 \" href=\"mobipreview.htm?22/39/23166\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Fundal massage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Begin fundal massage, which stimulates the atonic uterus to contract. An effective technique is to manually compress the corpus between the clinician's hands while applying fundal massage. One hand is made into a fist and placed in the anterior fornix, while the other provides abdominal hand massage for the fundus while firmly compressing it against the vaginal hand.",
"   </p>",
"   <p>",
"    The fundus should be massaged vigorously for at least 15 seconds and continued until the uterus remains firm and bleeding has abated. Massage should be maintained while other interventions are being initiated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Intravenous access",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ensure intravenous access, preferably with two large bore catheters (at least 16 or 18 gauge, ideally 14 gauge), for administration of fluids and blood (see",
"    <a class=\"local\" href=\"#H7\">",
"     'Fluid resuscitation and transfusion'",
"    </a>",
"    below), and medications (see",
"    <a class=\"local\" href=\"#H6\">",
"     'Uterotonic drugs'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3592966\">",
"    <span class=\"h2\">",
"     Oxygenation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Maximize oxygenation by administering oxygen (10 to 15",
"    <span class=\"nowrap\">",
"     liters/minute)",
"    </span>",
"    by face mask. An anesthesiologist should assess the patient&rsquo;s airway and breathing, and intubate if indicated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Laboratory tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Baseline laboratory evaluation should include a complete blood count and coagulation studies (fibrinogen concentration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/1\">",
"     1",
"    </a>",
"    ], platelet count, prothrombin time, activated partial thromboplastin time). In addition, the patient should be typed and crossed for multiple units of packed red blood cells. Thromboelastography and thromboelastometry, where available, may be useful for guiding transfusion therapy; there is minimal information on use of these tests in pregnancy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. In nonpregnant patients, values decline more rapidly than fibrinogen levels and can be useful for early guidance of interventions. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/44/23242?source=see_link&amp;anchor=H3046566855#H3046566855\">",
"     \"Coagulopathy associated with trauma\", section on 'Thromboelastography'",
"    </a>",
"    .).",
"   </p>",
"   <p>",
"    It is important to remember that the initial hemoglobin value does not reflect the amount of blood loss. Coagulation studies are usually normal initially, but may be abnormal in the presence of abruptio placentae, liver disease, intrauterine fetal demise, sepsis, or amniotic fluid embolism. Massive hemorrhage without replacement of coagulation factors will eventually result in coagulation abnormalities.",
"   </p>",
"   <p>",
"    Prior to the return of the first set of laboratory studies, a red top tube of 5 mL blood can be observed for clotting. If the blood in the tube clots within 8 to 10 minutes and the clot remains intact, the patient likely has adequate fibrinogen stores. If the blood in the tube does not clot or an initial clot dissolves, it is likely that the patient is markedly deficient in key clotting factors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The fibrinogen level at the time of diagnosis of PPH is predictive of the severity and can be used to guide the aggressiveness of management [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/1,6\">",
"     1,6",
"    </a>",
"    ]. In one study, a low fibrinogen level (less than 200",
"    <span class=\"nowrap\">",
"     mg/dL)",
"    </span>",
"    was predictive of severe postpartum hemorrhage defined as need for transfusion of multiple units of blood, need for angiographic embolization or surgical management of hemorrhage, or maternal death [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/1\">",
"     1",
"    </a>",
"    ]. In another study, compared with patients with fibrinogen &gt;300",
"    <span class=\"nowrap\">",
"     mg/dL,",
"    </span>",
"    the odds of severe PPH (hemoglobin decrease &ge;4",
"    <span class=\"nowrap\">",
"     g/dL,",
"    </span>",
"    red cell transfusion, arterial embolization or emergency surgery, admission to intensive care, or death) for patients with fibrinogen between 200 and 300",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    were almost doubled (OR 1.90, 95% CI 1.16&ndash;3.09) and increased 12-fold for fibrinogen less than 200",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (OR 11.99, 95% CI 2.56&ndash;56.06) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Uterotonic drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since atony is the most common cause of PPH, uterotonic drugs are administered for presumed atony until a therapeutic effect is observed. An",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/0/5125?source=see_link\">",
"     oxytocin",
"    </a>",
"    infusion is usually already running, but the rate can be increased (eg, to 500",
"    <span class=\"nowrap\">",
"     mL/hour).",
"    </span>",
"    We promptly proceed with one dose of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/50/32549?source=see_link\">",
"     methylergonovine",
"    </a>",
"    and then up to two doses of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/29/20948?source=see_link\">",
"     carboprost tromethamine",
"    </a>",
"    15 minutes apart. Some clinicians prefer to give the carboprost",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?42/29/43475?source=see_link\">",
"     tromethamine",
"    </a>",
"    first, or even omit the methylergonovine altogether. There is no evidence that one sequence is better than another.",
"   </p>",
"   <p>",
"    The important point is not the sequence of drugs, but the prompt initiation of uterotonic therapy and the prompt assessment of its effect. It should be possible to determine within 30 minutes whether pharmacological treatment will reverse uterine atony. If it does not, prompt invasive intervention is usually warranted.",
"   </p>",
"   <p>",
"    Options for uterotonic drugs include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?5/0/5125?source=see_link\">",
"       Oxytocin",
"      </a>",
"      40 units in 1 liter of normal saline intravenously at a rate sufficient to control uterine atony or 10 units intramuscularly (including directly into the myometrium). Higher doses of oxytocin (up to 80 units in 1000 mL) can be infused intravenously for a short duration (eg, over 30 minutes) to manage uterine atony [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/7\">",
"       7",
"      </a>",
"      ]. However, low doses (3 units) may be just as effective.",
"      <br/>",
"      <br/>",
"      Intravenous oxytocin may cause significant hypotension and cardiovascular collapse if given rapidly. These issues and dosing are discussed in more detail separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/42/41639?source=see_link&amp;anchor=H9#H9\">",
"       \"Uterotonic drugs for management of the third stage of labor\", section on 'Oxytocin'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/50/32549?source=see_link\">",
"       Methylergonovine",
"      </a>",
"      0.2 mg intramuscularly or directly into the myometrium (never intravenously), if no hypertension, Raynaud's phenomenon, or scleroderma. May repeat at two- to four-hour intervals, as needed. If there has not been a good response to the first dose, quickly move on to a different uterotonic agent.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?20/29/20948?source=see_link\">",
"       Carboprost tromethamine",
"      </a>",
"      (15 methyl-PGF2alpha)(Hemabate) 250 mcg intramuscularly (including directly into the myometrium) every 15 to 90 minutes, as needed, to a total cumulative dose of 2 mg (8 doses), if no asthma. About 75 percent of patients respond to a single dose; move on to a different uterotonic agent if no response after one or two doses.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?0/41/662?source=see_link\">",
"       Misoprostol",
"      </a>",
"      (PGE1) is most useful for reducing blood loss in settings where injectable uterotonics are unavailable or contraindicated [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/8-11\">",
"       8-11",
"      </a>",
"      ]. There is no strong evidence that misoprostol is useful as primary therapy of postpartum hemorrhage or as an adjunctive treatment of postpartum hemorrhage in addition to standard injectable uterotonics [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/8,10\">",
"       8,10",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      A randomized trial including 1422 women with PPH found that the proportion of women with blood loss &ge;500 mL or &ge;1000 mL was similar for those who received a standard injectable uterotonic (",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?5/0/5125?source=see_link\">",
"       oxytocin",
"      </a>",
"      10 IU intramuscularly or intravenously) plus misoprostol 600 mcg sublingually and controls who received the standard injectable uterotonic plus a placebo [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/10\">",
"       10",
"      </a>",
"      ]. In another randomized trial, after one dose of the standard injectable uterotonic (oxytocin 10 IU intramuscularly or intravenously), fewer women had additional blood loss &ge;1000 mL if they received another dose of oxytocin than if they received one dose of misoprostol",
"      <span class=\"nowrap\">",
"       (3/402",
"      </span>",
"      women (1 percent) versus",
"      <span class=\"nowrap\">",
"       11/407",
"      </span>",
"      women (3 percent); P = 0.06); there was no difference between groups for additional blood loss &ge;500 mL [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/8\">",
"       8",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      The optimum dose and route of misoprostol administration are unclear [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/12\">",
"       12",
"      </a>",
"      ]. Doses of 200 to 1000 mcg have been administered via oral, sublingual, and rectal routes or using a combination of routes [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/8,9,13-16\">",
"       8,9,13-16",
"      </a>",
"      ]. The sublingual route has both rapid onset (11 minutes) and good duration of action (3 hours), thus it is probably the optimal route of administration. A systematic review concluded that a dose of 400 mcg sublingually appeared to be as effective as 600 mcg and had fewer side effects, but available data on optimal dose were limited [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/17\">",
"       17",
"      </a>",
"      ]. Based on data from randomized trials, reasonable approaches include 200 mcg orally plus 400 mcg sublingually or 400 mcg sublingually or 600 mcg sublingually [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/12,15,17-19\">",
"       12,15,17-19",
"      </a>",
"      ]. Rectal administration has not been studied extensively. Rectal administration takes longer to achieve peak serum concentration compared with oral or sublingual administration (40 to 60 versus 30 minutes) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/20,21\">",
"       20,21",
"      </a>",
"      ]. The most commonly used rectal doses are 800 and 1000 mcg [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/13,14,22,23\">",
"       13,14,22,23",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Unlike",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/50/32549?source=see_link\">",
"       methylergonovine",
"      </a>",
"      and carboprost, misoprostol can be given to women with hypertension or asthma. Maternal temperature should be monitored closely, as pyrexia &ge;40 degrees Celsius can occur at these doses and should be treated (eg,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15802?source=see_link\">",
"       acetaminophen",
"      </a>",
"      ). The frequency of pyrexia increases with increasing misoprostol dose.",
"      <br/>",
"      <br/>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?13/38/13927?source=see_link\">",
"       Dinoprostone",
"      </a>",
"      (PGE2) 20 mg vaginal or rectal suppository is an alternative PGE to misoprostol (PGE1). It can be repeated at two-hour intervals.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/45/33491?source=see_link\">",
"       Carbetocin",
"      </a>",
"      , a long-acting analog of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?5/0/5125?source=see_link\">",
"       oxytocin",
"      </a>",
"      , is in use in many countries (but not the United States) for prevention of uterine atony and hemorrhage. In this capacity, it appears to be as effective as oxytocin [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/24\">",
"       24",
"      </a>",
"      ]. Carbetocin 100 mcg is given by a single slow intravenous injection. The toxicity spectrum is similar to that of oxytocin. It seems reasonable to use this drug as an alternative to oxytocin in countries where it is available, as it is easy to administer and has a short duration of action, but its efficacy in treating existing uterine atony is not well documented.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Fluid resuscitation and transfusion",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to monitoring vital signs, a bladder catheter with urimeter should be inserted to monitor urine output. Fluids and blood components should be normothermic to avoid hypothermia, which has been linked to coagulopathy in trauma patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. The patient should also be kept warm with blankets.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3593035\">",
"    <span class=\"h3\">",
"     Crystalloid",
"    </span>",
"    &nbsp;&mdash;&nbsp;A large volume of isotonic crystalloid is infused to prevent hypotension (target systolic pressure 90 mmHg) and maintain urine output at &gt;30",
"    <span class=\"nowrap\">",
"     mL/hour",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/27\">",
"     27",
"    </a>",
"    ]. A typical ratio is 3:1, ie, 3 liters of isotonic crystalloid for each 1 liter of estimated blood loss. Women with preeclampsia may have a contracted intravascular volume and hemoconcentration, and are prone to tissue hypoperfusion from blood loss.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3593077\">",
"    <span class=\"h3\">",
"     Transfusion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Replacement of blood components is more important than crystalloid infusion if massive hemorrhage has occurred or is likely [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/28\">",
"     28",
"    </a>",
"    ]. There are no universally accepted guidelines for replacement of blood components [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. Recommendations are usually based upon expert opinion since there is no good evidence from randomized trials.",
"   </p>",
"   <p>",
"    Before laboratory studies are available, we suggest transfusion of 2 units of packed red blood cells (pRBCs) if hemodynamics do not improve after the administration of 2 to 3 liters of normal saline, estimated blood loss is under 1500 mLs, and continued bleeding is likely. In addition, aggressive use of plasma replacement is important to reverse dilutional coagulopathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/31\">",
"     31",
"    </a>",
"    ]. There is no consensus on the optimal ratio of blood product replacement; recommendations for RBC:fresh frozen plasma (FFP): platelet ratios vary widely [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/29,32,33\">",
"     29,32,33",
"    </a>",
"    ]. Clinical experience in Iraq and Afghanistan, as well as domestic and foreign trauma centers and an obstetrical unit at a military hospital, suggest administration of 1 unit of FFP for every 1 to 2 units of RBCs until the clinical situation is stable or absence of coagulopathy is confirmed by laboratory studies (discussed below) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/28,34-36\">",
"     28,34-36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Institutions should adopt a massive transfusion protocol for patients with massive hemorrhage and continued bleeding; several such protocols exist, including:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Stanford University Medical Center: an initial package consisting of 6 units RBCs, 4 units FFP, and 1 apheresis platelet unit [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/33\">",
"       33",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Brigham and Women's Hospital: immediate availability of 2 units RBCs and 2 units of FFP followed by 4 units each of RBCs and FFP and thawing of one pool (6 bags) cryoprecipitate.",
"     </li>",
"     <li>",
"      For patients with unstable vital signs, suspicion of DIC, or blood loss &gt;1500 mLs, the California Maternal Quality Care Collaborative OB Hemorrhage Protocol transfuses pRBC, FFP, and platelets in a ratio of 6:4:1 or 4:4:1. If coagulopathy persists after 8 to 10 units pRBCs and coagulation factor replacement, recombinant activated factor VIIa is a reasonable option. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Recombinant activated factor VII'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Virus-inactivated",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?14/20/14659?source=see_link\">",
"     fibrinogen concentrate",
"    </a>",
"    (RiaSTAP) may be used when fibrinogen levels are critically low (ie, &lt;100",
"    <span class=\"nowrap\">",
"     mg/dL),",
"    </span>",
"    and FFP and cryoprecipitate are not available. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/25/38294?source=see_link\">",
"     \"Massive blood transfusion\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    We estimate blood loss and draw laboratory studies every 30 to 60 minutes to guide blood product replacement. We continue to transfuse RBCs, platelets, cryoprecipitate, and FFP to achieve the following targets:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Hemoglobin greater than 7.5",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"     </li>",
"     <li>",
"      Platelet count greater than",
"      <span class=\"nowrap\">",
"       50,000/uL",
"      </span>",
"     </li>",
"     <li>",
"      Fibrinogen greater than 100",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"     </li>",
"     <li>",
"      Prothrombin (PT) and partial thromboplastin time (PTT) less than 1.5 times control",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    As an example, 4 units of FFP are given if the INR is more than 1.5, one apheresis platelet pack is given if the platelet count is less than",
"    <span class=\"nowrap\">",
"     50,000/microL,",
"    </span>",
"    and 10 bags of cryoprecipitate are given if the fibrinogen is less than 100",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (",
"    <a class=\"graphic graphic_table graphicRef53854 \" href=\"mobipreview.htm?41/3/42043\">",
"     table 2",
"    </a>",
"    ). Most providers continue to transfuse patients with hemoglobin values less than 7.5 to 8",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/37\">",
"     37",
"    </a>",
"    ]. A hemoglobin level of at least 8.0",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    after transfusion has been recommended since values below this level can be associated with impaired hemostasis from lower platelet adhesion and high blood velocity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/38\">",
"     38",
"    </a>",
"    ], as well as myocardial ischemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/27\">",
"     27",
"    </a>",
"    ]. Transfusion is rarely indicated when the hemoglobin is greater than 10",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The Blood Bank should have compatible blood available for massive transfusion in obstetric emergencies, and eliminate barriers to rapid access of uncrossmatched blood when needed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/33,40\">",
"     33,40",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/25/38294?source=see_link\">",
"     \"Massive blood transfusion\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/38/42600?source=see_link&amp;anchor=H12#H12\">",
"     \"Overview of postpartum hemorrhage\", section on 'Management'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Issues relating to patients who are unwilling to accept transfusions (eg, Jehovah's Witnesses) are addressed in a separate topic review. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/46/10986?source=see_link\">",
"     \"The approach to the patient who refuses blood transfusion\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The following UpToDate topic reviews discuss blood transfusion therapy in detail:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?5/52/5961?source=see_link\">",
"       \"Indications for red cell transfusion in the adult\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/55/29562?source=see_link\">",
"       \"Initial evaluation and management of shock in adult trauma\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?20/37/21081?source=see_link\">",
"       \"Use of red blood cells for transfusion\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?37/25/38294?source=see_link\">",
"       \"Massive blood transfusion\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     SECONDARY INTERVENTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;At the same time as we institute resuscitative measures and compress the uterus, we examine the birth canal with the woman in stirrups (dorsal lithotomy position) in a room with facilities for general anesthesia and both vaginal and abdominal surgery. Lower genital sources of bleeding (eg, lacerations, uterine inversion) can usually be readily identified by visualizing the birth canal. Adequate assistance, exposure, lighting, instruments, and anesthesia are necessary to perform a thorough examination.",
"   </p>",
"   <p>",
"    Ideally, hemostatic defects will have been corrected prior to invasive measures directed at treating uterine atony, but such measures should not be delayed if bleeding cannot be controlled promptly. In the presence of massive bleeding secondary to uterine atony, blood product replacement concurrent with initiation of invasive procedures is necessary. An invasive intervention such as balloon tamponade, arterial embolization, uterine compression sutures, or uterine devascularization successfully controls hemorrhage in 85 to 90 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The following sequence of steps is initiated:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Provide adequate anesthesia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Local anesthesia rarely provides sufficient pain relief for thorough examination and treatment; regional or general anesthesia should be administered. The choice of anesthetic depends upon the patient's hemodynamic status and planned interventions, and should be made in consultation with an anesthesiologist.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Examine the vagina and cervix",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although rare, complete uterine inversion commonly presents with postpartum hemorrhage and is readily diagnosed on examination of the vagina. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/34/8743?source=see_link\">",
"     \"Puerperal uterine inversion\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The entire birth canal from perineum to cervix should be inspected for significant lacerations. The uterine cavity should be palpated for defects indicating uterine rupture or dehiscence. This examination should be performed in all patients with PPH who delivered vaginally, as well as those who attained significant cervical dilatation and descent of the presenting fetal part before a cesarean delivery. Even if inspection for lacerations had already been performed at delivery (or afterwards without adequate analgesia), a thorough examination should be repeated, as it is possible that a bleeding site was missed. Risk factors for significant cervical lacerations (ie, associated with excessive bleeding or requiring repair) include precipitous labor, operative vaginal delivery, and cerclage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/42\">",
"     42",
"    </a>",
"    ]. However, absence of such risk factors should not preclude reexamination of the birth canal.",
"   </p>",
"   <p>",
"    We repair heavily bleeding vaginal and cervical lacerations with a running locked #0 absorbable suture. Exposure is facilitated by using a Gelpi retractor (",
"    <a class=\"graphic graphic_figure graphicRef65767 \" href=\"mobipreview.htm?11/39/11903\">",
"     figure 1",
"    </a>",
"    ) to spread the distal vaginal sidewalls and Heaney (",
"    <a class=\"graphic graphic_figure graphicRef70162 \" href=\"mobipreview.htm?33/44/34498\">",
"     figure 2",
"    </a>",
"    ) or Breisky (",
"    <a class=\"graphic graphic_figure graphicRef53830 \" href=\"mobipreview.htm?25/62/26607\">",
"     figure 3",
"    </a>",
"    ) retractors to access the upper vagina. If available, use of several assistants with Deaver retractors placed laterally is also effective.",
"   </p>",
"   <p>",
"    It is often difficult to begin a suture line at the apex of the laceration because of problems with exposure and visualization. In such cases, one can begin the suture line at the distal end of the laceration and sew toward the apex, while using the suture to pull the lacerated tissue toward the surgeon.",
"   </p>",
"   <p>",
"    Two pitfalls to avoid:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Sutures should not be placed cephalad to the fornix, as this can result in ureteral ligation. When an extension exists high in the vagina, possibly extending into the cardinal ligament, we perform a laparotomy. The patient's thighs are abducted in stirrups to allow surgery to proceed simultaneously via the abdominal and vaginal routes, as needed for optimal exposure and access. This facilitates identification of the bladder and ureters, minimizing the chance of inadvertent damage to these structures.",
"     </li>",
"     <li>",
"      Vaginal hematomas should not be drained unless expanding. Attempts at operative drainage can result in significant additional blood loss because it is often difficult to identify and ligate bleeding vessels in a fresh vaginal sulcus hematoma. A stable hematoma may be drained later if it becomes infected or pain is not relieved adequately with analgesics. Continuous expansion of a hematoma leading to hypovolemia may necessitate drainage and packing. Alternatively, embolization may be the best approach. Management of vaginal hematomas is discussed in more detail separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?43/2/44071?source=see_link\">",
"       \"Evaluation and management of lower genital tract trauma in women\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Exclude uterine rupture",
"    </span>",
"    &nbsp;&mdash;&nbsp;Uterine rupture is most common in the scarred uterus, but rupture of the unscarred uterus can occur, particularly if labor was induced or augmented. Postpartum, uterine rupture is often characterized by pain and persistent vaginal bleeding despite use of uterotonic agents. Hematuria may occur if the rupture extends into the bladder. Maternal symptoms of hypovolemia that appear to be out of proportion to observed blood loss and abdominal distention should also prompt consideration of intraabdominal hemorrhage. Palpation of the uterine cavity may reveal the opening, and ultrasound examination will reveal blood in the abdomen",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a broad ligament hematoma. Risk factors, clinical manifestations, diagnosis, and management of uterine rupture are reviewed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/10/5290?source=see_link\">",
"     \"Choosing the route of delivery after cesarean birth\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Remove retained products of conception",
"    </span>",
"    &nbsp;&mdash;&nbsp;The uterus should be explored and any retained placental fragments or fetal membranes should be removed manually, if possible, or with ring forceps. Ultrasound examination can be helpful for diagnosis of retained tissue and to guide removal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/43,44\">",
"     43,44",
"    </a>",
"    ]. Curettage with a 16 mm suction catheter or (preferably) a large blunt curette (banjo curette) is performed if manual removal is unsuccessful in controlling hemorrhage.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Uterine tamponade",
"    </span>",
"    &nbsp;&mdash;&nbsp;Uterine tamponade is effective in many patients with atony or lower segment bleeding. In the setting of cardiovascular instability, however, it is important to avoid prolonged, futile attempts at temporizing measures rather than proceeding to laparotomy and, if necessary, hysterectomy.",
"   </p>",
"   <p>",
"    Either a balloon or a pack can be used for tamponade, but a balloon device designed for uterine tamponade is preferable because it can be placed quickly, allows some assessment of ongoing hemorrhage, and is probably more effective [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/45\">",
"     45",
"    </a>",
"    ]. Regardless of the method employed, hemoglobin, continued blood loss, and urine output should be closely monitored. This is especially important when a gauze pack is used because a large amount of blood can collect behind the pack. The balloon or pack is removed after 24 hours.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Balloons",
"    </span>",
"    &nbsp;&mdash;&nbsp;Devices such as the Bakri tamponade balloon, the BT-Cath, Sengstaken-Blakemore tube, and #24 Foley catheter with a 30 mL balloon have been used successfully to tamponade the uterine cavity. The Bakri balloon and BT-Cath were designed specifically for this purpose. For each device, the balloon is filled until bleeding is controlled. Continued excessive bleeding indicates that tamponade is not effective and surgery or embolization should be performed. The use of these devices is described in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/11/22711?source=see_link\">",
"     \"Intrauterine balloon tamponade for control of postpartum hemorrhage\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Packs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Uterine packs have also been used to control PPH with variable success; proper technique requires firmly packing the entire uterine cavity with gauze, such as Kerlix, to achieve tamponade [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/46-48\">",
"     46-48",
"    </a>",
"    ]. The gauze can be impregnated with 5000 units thrombin in 5 mL sterile saline to enhance clotting. A regimen of intravenous broad spectrum antibiotics, such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/10/36000?source=see_link\">",
"     gentamicin",
"    </a>",
"    , 1.5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    every eight hours, and either",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/38/20065?source=see_link\">",
"     metronidazole",
"    </a>",
"    , 500 mg every eight hours, or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/21/33104?source=see_link\">",
"     clindamycin",
"    </a>",
"    , 300 mg every six hours, are administered while the pack is in place. If packing does not control hemorrhage, repacking is not advised [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Arterial embolization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Arterial embolization by an interventional radiologist is an option if the woman is hemodynamically stable and personnel and facilities are readily available. Consultation with an interventional radiologist should be obtained early in the patient's course. This facilitates decision making about the possible need for, and timing of, a procedure. Decision making and mobilization of personnel and appropriate equipment take time and, in some cases, a significant delay is likely before the uterine vessels can be occluded. Laparotomy should be performed if the woman is not stable enough to wait for the embolization procedure.",
"   </p>",
"   <p>",
"    If coagulopathy is present, it should be corrected before the procedure, although some radiologists will go ahead while the coagulopathy is being treated since the hemorrhage is generally the cause of the coagulopathy. Others consider coagulopathy a relative contraindication to elective interventional procedures; however, under emergency situations, it can be performed as a life-saving measure even with coagulopathy.",
"   </p>",
"   <p>",
"    If the embolization is unsuccessful, uterine artery ligation can be attempted subsequently. In contrast, embolization after a failed uterine artery ligation is more difficult [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/50,51\">",
"     50,51",
"    </a>",
"    ], although not impossible. In one study, arterial embolization was successful in 10 of 11 cases of failed surgical ligation therapy for PPH [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/52\">",
"     52",
"    </a>",
"    ]. Thus, uterine arterial embolization should be considered an option even after failed surgical ligation due to",
"    <span class=\"nowrap\">",
"     incomplete/ineffective",
"    </span>",
"    occlusion.",
"   </p>",
"   <p>",
"    The technique of embolization is basically the same as with other embolization procedures. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/44/30408?source=see_link\">",
"     \"Interventional radiology in management of gynecological disorders\"",
"    </a>",
"    .) Diagnostic angiography is initially performed to look for a bleeding site or abnormal vascular findings, such as extravasation, abnormal arteriovenous communication, pseudoaneurysm, spasm, or truncation (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef67041 graphicRef78839 \" href=\"mobipreview.htm?25/40/26243\">",
"     image 1A-B",
"    </a>",
"    ). Gelfoam is the preferred agent for embolization of the uterine or hypogastric arteries since the duration of occlusion is temporary (two to six weeks), but sufficient to reduce hemorrhage. Slow development of collateral arterial flow occurs a few hours after embolization and serves to prevent ischemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/53,54\">",
"     53,54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The patient's physician should monitor her status in the angiography suite at the time of the procedure and be ready to proceed to surgical intervention if the patient becomes hemodynamically unstable. Frequent communication about the patient's status between the interventional radiologist and the physician is important. A prolonged embolization procedure should be avoided if there appears to be little chance of therapeutic success because the patient's condition may deteriorate and increase the risk of surgical intervention.",
"   </p>",
"   <p>",
"    If the procedure is unsuccessful and time permits, angiographic occlusion balloon catheters can be placed to temporarily occlude the hypogastric or common iliac arteries (or even in the aorta) while en route to the operating room or during the surgery. Prolonged (48 hours) balloon catheter occlusion of the hypogastric arteries alone, without embolization, was reported to successfully control hemorrhage in two hemodynamically unstable patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A literature review of uterine artery embolization for treatment of pelvic hemorrhage unrelated to malignancy reported a 97 percent success rate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/51\">",
"     51",
"    </a>",
"    ]. Another review described a 95 percent success rate in controlling bleeding related to postpartum hemorrhage; the failure rate was low (5 percent of cases required hysterectomy) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/54\">",
"     54",
"    </a>",
"    ]. A large series of 100 cases performed at a single center mostly by one radiologist reported 89 percent success for control of postpartum hemorrhage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Serious complications are unusual and the procedure-related morbidity of 3 to 6 percent is much less than with laparotomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/51,52,56,57\">",
"     51,52,56,57",
"    </a>",
"    ]. Postembolization fever is the most common complication; other less common complications include buttock ischemia, vascular perforation, uterine necrosis, and infection. Ovulation and menses generally resume as long as the uterus and ovaries are intact.",
"   </p>",
"   <p>",
"    Case reports and small case series have consistently reported that menstrual function and fertility return to baseline after arterial embolization for PPH, and subsequent pregnancies do not experience any increase in adverse outcome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/58-68\">",
"     58-68",
"    </a>",
"    ]. This experience appears to contradict the reports describing increased pregnancy loss after uterine artery embolization for treatment of leiomyomas. Possible reasons for this discordance include the typically younger age of pregnant patients, the vastly increased vascularization of the gravid uterus (possibly permitting formation of more adequate alternative blood supply), and the absence of leiomyomas in the gravid patients. It is also possible that arterial embolization of the gravid uterus is associated with an increased incidence of subsequent pregnancy loss above baseline, but there is a lack of literature supporting this.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Recombinant activated factor VII",
"    </span>",
"    &nbsp;&mdash;&nbsp;Human recombinant activated factor VII (rFVIIa) has been approved by the United States Food and Drug Administration for treatment of individuals with bleeding related to hemophilia A and B inhibitors, acquired inhibitors, and congenital factor VII deficiency. It has also been used successfully off-label for control of bleeding in other situations, such as intractable bleeding associated with postpartum uterine atony, placenta accreta, or uterine rupture [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/69,70\">",
"     69,70",
"    </a>",
"    ]. Although this therapy appears promising when standard therapy fails [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/70,71\">",
"     70,71",
"    </a>",
"    ], the drug is very expensive and may increase the risk of thromboembolic events [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/72\">",
"     72",
"    </a>",
"    ], thus it should be reserved for cases of intractable hemorrhage and coagulopathy.",
"   </p>",
"   <p>",
"    Doses of 16.7 to 120",
"    <span class=\"nowrap\">",
"     mcg/kg",
"    </span>",
"    as a single bolus injection over a few minutes every two hours until hemostasis is achieved have been effective, and usually control bleeding within 10 to 40 minutes of the first dose [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/69,73\">",
"     69,73",
"    </a>",
"    ]. It is preferable to start with a low dose to reduce the risk of thromboembolic events; 40",
"    <span class=\"nowrap\">",
"     mcg/kg",
"    </span>",
"    has been suggested for obstetric hemorrhage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/74\">",
"     74",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The efficacy of rFVIIa depends on the levels of other coagulation factors present, patient temperature, and pH. For maximal effectiveness, the patient should have an adequate platelet count",
"    <span class=\"nowrap\">",
"     (&gt;50,000/mm",
"     <sup>",
"      3",
"     </sup>",
"     )",
"    </span>",
"    and fibrinogen level (&gt;50 to 100",
"    <span class=\"nowrap\">",
"     mg/dL),",
"    </span>",
"    and near normal temperature, pH, and calcium levels [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/75\">",
"     75",
"    </a>",
"    ]. Thus, major sources of bleeding should be controlled and blood products administered to correct major deficiencies before administering rFVIIa. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/13/31962?source=see_link\">",
"     \"Therapeutic uses of recombinant coagulation factor VIIa\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     INDICATIONS FOR LAPAROTOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;If vital signs are worse than expected for the estimated blood loss, the possibility of internal hemorrhage should be considered, particularly in women who had an operative vaginal delivery or are otherwise at risk of uterine rupture (see",
"    <a class=\"local\" href=\"#H11\">",
"     'Exclude uterine rupture'",
"    </a>",
"    above). Laparotomy to assess and treat suspected pelvic bleeding should be performed through a vertical midline incision to provide exposure of both the pelvis and abdomen. A self-retaining retractor, such as a Balfour, provides adequate lateral exposure.",
"   </p>",
"   <p>",
"    Extrauterine bleeding can usually be identified without difficulty. If a discrete vessel is responsible for hemorrhage, it is clamped and ligated with appropriate suture material. Bleeding adjacent to the uterus without clear bleeding points is treated by ligation of uterine vessels.",
"   </p>",
"   <p>",
"    As discussed above, we perform a laparotomy when a vaginal laceration has extended above the fornix. The patient's thighs are abducted in stirrups to allow surgery to proceed simultaneously via the abdominal and vaginal routes, as needed, for optimal exposure and access. This facilitates identification of the bladder and ureters, minimizing the chance of inadvertently damaging these structures.",
"   </p>",
"   <p>",
"    Laparotomy is also indicated for management of uterine atony unresponsive to the conservative interventions described above. The uterine vessels are ligated",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    uterine compression sutures are placed. The need for laparotomy is rare, as the combination of balloon tamponade and uterine artery embolization controls bleeding in virtually all cases.",
"   </p>",
"   <p>",
"    Surgical techniques for control of hemorrhage at laparotomy are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/44/27336?source=see_link&amp;anchor=H6#H6\">",
"     \"Management of postpartum hemorrhage at cesarean delivery\", section on 'Uterine artery and utero-ovarian artery ligation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Hysterectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hysterectomy is the last resort, but should not be delayed in women who require prompt control of uterine hemorrhage to prevent death. Continued blood loss can lead to disseminated intravascular coagulation due to massive loss of coagulation factors. Severe hypovolemia, tissue hypoxia, hypothermia, and acidosis can result, which further compromise the patient's status. If the patient is not already at laparotomy and has developed these additional complications, then correction of the severe physiological deficits before hysterectomy, if possible, could be life-saving [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/60/41929/abstract/76,77\">",
"     76,77",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/43/29367?source=see_link\">",
"     \"Peripartum hysterectomy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?37/15/38129?source=see_link\">",
"       \"Patient information: Postpartum hemorrhage (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We recommend initial management of primary postpartum hemorrhage after vaginal delivery include fundal massage, placement of large bore intravenous lines and bladder catheter, crystalloid infusion, administration of uterotonic agents, and transfusion of blood products as needed (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). We begin an",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?5/0/5125?source=see_link\">",
"       oxytocin",
"      </a>",
"      infusion and then promptly proceed with the following interventions one by one until the hemorrhage is controlled: one dose of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/50/32549?source=see_link\">",
"       methylergonovine",
"      </a>",
"      and then up to two doses of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?20/29/20948?source=see_link\">",
"       carboprost tromethamine",
"      </a>",
"      .",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?0/41/662?source=see_link\">",
"       Misoprostol",
"      </a>",
"      (PGE1) is most useful for reducing blood loss in settings where injectable uterotonics are unavailable. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Initial interventions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If these measures do not control hemorrhage, we suggest secondary management include the following sequence of interventions: assessment for and repair of lacerations (if present), removal of retained placenta and fetal membranes, uterine balloon tamponade, and uterine artery ligation (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      If selective arterial embolization is readily available, we suggest this procedure before laparotomy for uterine artery ligation, given that embolization is a less morbid procedure and is more difficult to perform after ligation if ligation is unsuccessful (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). A list of potential therapeutic interventions is provided in the table (",
"      <a class=\"graphic graphic_table graphicRef73412 \" href=\"mobipreview.htm?30/26/31148\">",
"       table 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Secondary interventions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Laparotomy is indicated for management of uterine atony unresponsive to more conservative interventions or if intraabdominal hemorrhage is suspected. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Indications for laparotomy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hysterectomy is a last resort, but should not be delayed in women who have disseminated intravascular coagulation and require prompt control of uterine hemorrhage to prevent death. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Hysterectomy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/1\">",
"      Charbit B, Mandelbrot L, Samain E, et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost 2007; 5:266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/2\">",
"      de Lange NM, Lanc&eacute; MD, de Groot R, et al. Obstetric hemorrhage and coagulation: an update. Thromboelastography, thromboelastometry, and conventional coagulation tests in the diagnosis and prediction of postpartum hemorrhage. Obstet Gynecol Surv 2012; 67:426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/3\">",
"      Della Rocca G, Dogareschi T, Cecconet T, et al. Coagulation assessment in normal pregnancy: thrombelastography with citrated non activated samples. Minerva Anestesiol 2012; 78:1357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/4\">",
"      Karlsson O, Sporrong T, Hillarp A, et al. Prospective longitudinal study of thromboelastography and standard hemostatic laboratory tests in healthy women during normal pregnancy. Anesth Analg 2012; 115:890.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/5\">",
"      POE MF. Clot observation test for clinical diagnosis of clotting defects. Anesthesiology 1959; 20:825.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/6\">",
"      Cortet M, Deneux-Tharaux C, Dupont C, et al. Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial. Br J Anaesth 2012; 108:984.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/7\">",
"      Munn MB, Owen J, Vincent R, et al. Comparison of two oxytocin regimens to prevent uterine atony at cesarean delivery: a randomized controlled trial. Obstet Gynecol 2001; 98:386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/8\">",
"      Blum J, Winikoff B, Raghavan S, et al. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women receiving prophylactic oxytocin: a double-blind, randomised, non-inferiority trial. Lancet 2010; 375:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/9\">",
"      Winikoff B, Dabash R, Durocher J, et al. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women not exposed to oxytocin during labour: a double-blind, randomised, non-inferiority trial. Lancet 2010; 375:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/10\">",
"      Widmer M, Blum J, Hofmeyr GJ, et al. Misoprostol as an adjunct to standard uterotonics for treatment of post-partum haemorrhage: a multicentre, double-blind randomised trial. Lancet 2010; 375:1808.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/11\">",
"      Mousa HA, Alfirevic Z. Treatment for primary postpartum haemorrhage. Cochrane Database Syst Rev 2007; :CD003249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/12\">",
"      Hofmeyr GJ, Walraven G, G&uuml;lmezoglu AM, et al. Misoprostol to treat postpartum haemorrhage: a systematic review. BJOG 2005; 112:547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/13\">",
"      O'Brien P, El-Refaey H, Gordon A, et al. Rectally administered misoprostol for the treatment of postpartum hemorrhage unresponsive to oxytocin and ergometrine: a descriptive study. Obstet Gynecol 1998; 92:212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/14\">",
"      Lokugamage AU, Sullivan KR, Niculescu I, et al. A randomized study comparing rectally administered misoprostol versus Syntometrine combined with an oxytocin infusion for the cessation of primary post partum hemorrhage. Acta Obstet Gynecol Scand 2001; 80:835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/15\">",
"      Walraven G, Dampha Y, Bittaye B, et al. Misoprostol in the treatment of postpartum haemorrhage in addition to routine management: a placebo randomised controlled trial. BJOG 2004; 111:1014.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/16\">",
"      Hofmeyr GJ, Ferreira S, Nikodem VC, et al. Misoprostol for treating postpartum haemorrhage: a randomized controlled trial [ISRCTN72263357]. BMC Pregnancy Childbirth 2004; 4:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/17\">",
"      Hofmeyr GJ, G&uuml;lmezoglu AM, Novikova N, et al. Misoprostol to prevent and treat postpartum haemorrhage: a systematic review and meta-analysis of maternal deaths and dose-related effects. Bull World Health Organ 2009; 87:666.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/18\">",
"      Blum J, Alfirevic Z, Walraven G, et al. Treatment of postpartum hemorrhage with misoprostol. Int J Gynaecol Obstet 2007; 99 Suppl 2:S202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/19\">",
"      Zuberi NF, Durocher J, Sikander R, et al. Misoprostol in addition to routine treatment of postpartum hemorrhage: a hospital-based randomized-controlled trial in Karachi, Pakistan. BMC Pregnancy Childbirth 2008; 8:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/20\">",
"      Tang OS, Schweer H, Seyberth HW, et al. Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod 2002; 17:332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/21\">",
"      Tang OS, Gemzell-Danielsson K, Ho PC. Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects. Int J Gynaecol Obstet 2007; 99 Suppl 2:S160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/22\">",
"      Shojai R, Desbri&egrave;re R, Dhifallah S, et al. [Rectal misoprostol for postpartum hemorrhage]. Gynecol Obstet Fertil 2004; 32:703.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/23\">",
"      Nasr A, Shahin AY, Elsamman AM, et al. Rectal misoprostol versus intravenous oxytocin for prevention of postpartum hemorrhage. Int J Gynaecol Obstet 2009; 105:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/24\">",
"      Su LL, Chong YS, Samuel M. Oxytocin agonists for preventing postpartum haemorrhage. Cochrane Database Syst Rev 2007; :CD005457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/25\">",
"      Ferrara A, MacArthur JD, Wright HK, et al. Hypothermia and acidosis worsen coagulopathy in the patient requiring massive transfusion. Am J Surg 1990; 160:515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/26\">",
"      Watts DD, Trask A, Soeken K, et al. Hypothermic coagulopathy in trauma: effect of varying levels of hypothermia on enzyme speed, platelet function, and fibrinolytic activity. J Trauma 1998; 44:846.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/27\">",
"      Karpati PC, Rossignol M, Pirot M, et al. High incidence of myocardial ischemia during postpartum hemorrhage. Anesthesiology 2004; 100:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/28\">",
"      Holcomb JB, Jenkins D, Rhee P, et al. Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma 2007; 62:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/29\">",
"      Spahn DR, Rossaint R. Coagulopathy and blood component transfusion in trauma. Br J Anaesth 2005; 95:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/30\">",
"      Fuller AJ, Bucklin B. Blood component therapy in obstetrics. Obstet Gynecol Clin North Am 2007; 34:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/31\">",
"      Ho AM, Dion PW, Cheng CA, et al. A mathematical model for fresh frozen plasma transfusion strategies during major trauma resuscitation with ongoing hemorrhage. Can J Surg 2005; 48:470.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/32\">",
"      Gonzalez EA, Moore FA, Holcomb JB, et al. Fresh frozen plasma should be given earlier to patients requiring massive transfusion. J Trauma 2007; 62:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/33\">",
"      Burtelow M, Riley E, Druzin M, et al. How we treat: management of life-threatening primary postpartum hemorrhage with a standardized massive transfusion protocol. Transfusion 2007; 47:1564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/34\">",
"      Ketchum L, Hess JR, Hiippala S. Indications for early fresh frozen plasma, cryoprecipitate, and platelet transfusion in trauma. J Trauma 2006; 60:S51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/35\">",
"      Davenport R, Curry N, Manson J, et al. Hemostatic effects of fresh frozen plasma may be maximal at red cell ratios of 1:2. J Trauma 2011; 70:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/36\">",
"      Pasquier P, Gayat E, Rackelboom T, et al. An observational study of the fresh frozen plasma: red blood cell ratio in postpartum hemorrhage. Anesth Analg 2013; 116:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/37\">",
"      Matot I, Einav S, Goodman S, et al. A survey of physicians' attitudes toward blood transfusion in patients undergoing cesarean section. Am J Obstet Gynecol 2004; 190:462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/38\">",
"      Jansen AJ, van Rhenen DJ, Steegers EA, Duvekot JJ. Postpartum hemorrhage and transfusion of blood and blood components. Obstet Gynecol Surv 2005; 60:663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/39\">",
"      American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 2006; 105:198.",
"     </a>",
"    </li>",
"    <li>",
"     Novello, A, King, JC. Health Advisory: Prevention of Maternal Deaths Through Improved Managementof Hemorrhage. www.acog.org/acog_districts/dist_notice.cfm?recno=1&amp;bulletin=1517 (accessed May 2, 2006).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/41\">",
"      Doumouchtsis SK, Papageorghiou AT, Arulkumaran S. Systematic review of conservative management of postpartum hemorrhage: what to do when medical treatment fails. Obstet Gynecol Surv 2007; 62:540.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/42\">",
"      Melamed N, Ben-Haroush A, Chen R, et al. Intrapartum cervical lacerations: characteristics, risk factors, and effects on subsequent pregnancies. Am J Obstet Gynecol 2009; 200:388.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/43\">",
"      American College of Obstetricians and Gynecologists. ACOG Practice Bulletin: Clinical Management Guidelines for Obstetrician-Gynecologists Number 76, October 2006: postpartum hemorrhage. Obstet Gynecol 2006; 108:1039.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/44\">",
"      Lousquy R, Morel O, Soyer P, et al. Routine use of abdominopelvic ultrasonography in severe postpartum hemorrhage: retrospective evaluation in 125 patients. Am J Obstet Gynecol 2011; 204:232.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/45\">",
"      Georgiou C. Balloon tamponade in the management of postpartum haemorrhage: a review. BJOG 2009; 116:748.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/46\">",
"      Maier RC. Control of postpartum hemorrhage with uterine packing. Am J Obstet Gynecol 1993; 169:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/47\">",
"      Hester JD. Postpartum hemorrhage and reevaluation of uterine packing. Obstet Gynecol 1975; 45:501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/48\">",
"      Hsu S, Rodgers B, Lele A, Yeh J. Use of packing in obstetric hemorrhage of uterine origin. J Reprod Med 2003; 48:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/49\">",
"      LESTER WM, BARTHOLOMEW RA, COLVIN ED, et al. RECONSIDERATION OF THE UTERINE PACK IN POSTPARTUM HEMORRHAGE. Am J Obstet Gynecol 1965; 93:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/50\">",
"      Mason BA. Postpartum hemorrhage and arterial embolization. Curr Opin Obstet Gynecol 1998; 10:475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/51\">",
"      Vedantham S, Goodwin SC, McLucas B, Mohr G. Uterine artery embolization: an underused method of controlling pelvic hemorrhage. Am J Obstet Gynecol 1997; 176:938.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/52\">",
"      Sentilhes L, Gromez A, Clavier E, et al. Predictors of failed pelvic arterial embolization for severe postpartum hemorrhage. Obstet Gynecol 2009; 113:992.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/53\">",
"      Hansch E, Chitkara U, McAlpine J, et al. Pelvic arterial embolization for control of obstetric hemorrhage: a five-year experience. Am J Obstet Gynecol 1999; 180:1454.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/54\">",
"      Badawy SZ, Etman A, Singh M, et al. Uterine artery embolization: the role in obstetrics and gynecology. Clin Imaging 2001; 25:288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/55\">",
"      Oei SG, Kho SN, ten Broeke ED, Br&ouml;lmann HA. Arterial balloon occlusion of the hypogastric arteries: a life-saving procedure for severe obstetric hemorrhage. Am J Obstet Gynecol 2001; 185:1255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/56\">",
"      Alvarez M, Lockwood CJ, Ghidini A, et al. Prophylactic and emergent arterial catheterization for selective embolization in obstetric hemorrhage. Am J Perinatol 1992; 9:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/57\">",
"      Tseng JT, Ho JYP, Wen MC, Hwang JI. Uterine necrosis associated with acute suppurative myometritis after angiographic selective embolization for refractory postpartum hemorrhage. Am J Obstet Gynecol 2011; 204.e4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/58\">",
"      Picone O, Salomon LJ, Ville Y, et al. Fetal growth and Doppler assessment in patients with a history of bilateral internal iliac artery embolization. J Matern Fetal Neonatal Med 2003; 13:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/59\">",
"      Ornan D, White R, Pollak J, Tal M. Pelvic embolization for intractable postpartum hemorrhage: long-term follow-up and implications for fertility. Obstet Gynecol 2003; 102:904.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/60\">",
"      Descargues G, Mauger Tinlot F, Douvrin F, et al. Menses, fertility and pregnancy after arterial embolization for the control of postpartum haemorrhage. Hum Reprod 2004; 19:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/61\">",
"      Wang H, Garmel S. Successful term pregnancy after bilateral uterine artery embolization for postpartum hemorrhage. Obstet Gynecol 2003; 102:603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/62\">",
"      Eriksson LG, Mulic-Lutvica A, Jangland L, Nyman R. Massive postpartum hemorrhage treated with transcatheter arterial embolization: technical aspects and long-term effects on fertility and menstrual cycle. Acta Radiol 2007; 48:635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/63\">",
"      Chauleur C, Fanget C, Tourne G, et al. Serious primary post-partum hemorrhage, arterial embolization and future fertility: a retrospective study of 46 cases. Hum Reprod 2008; 23:1553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/64\">",
"      Shim JY, Yoon HK, Won HS, et al. Angiographic embolization for obstetrical hemorrhage: effectiveness and follow-up outcome of fertility. Acta Obstet Gynecol Scand 2006; 85:815.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/65\">",
"      Fiori O, Deux JF, Kambale JC, et al. Impact of pelvic arterial embolization for intractable postpartum hemorrhage on fertility. Am J Obstet Gynecol 2009; 200:384.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/66\">",
"      Alanis M, Hurst BS, Marshburn PB, Matthews ML. Conservative management of placenta increta with selective arterial embolization preserves future fertility and results in a favorable outcome in subsequent pregnancies. Fertil Steril 2006; 86:1514.e3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/67\">",
"      Sentilhes L, Gromez A, Clavier E, et al. Fertility and pregnancy following pelvic arterial embolisation for postpartum haemorrhage. BJOG 2010; 117:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/68\">",
"      Hardeman S, Decroisette E, Marin B, et al. Fertility after embolization of the uterine arteries to treat obstetrical hemorrhage: a review of 53 cases. Fertil Steril 2010; 94:2574.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/69\">",
"      Franchini M, Lippi G, Franchi M. The use of recombinant activated factor VII in obstetric and gynaecological haemorrhage. BJOG 2007; 114:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/70\">",
"      Phillips LE, McLintock C, Pollock W, et al. Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry. Anesth Analg 2009; 109:1908.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/71\">",
"      Welsh A, McLintock C, Gatt S, et al. Guidelines for the use of recombinant activated factor VII in massive obstetric haemorrhage. Aust N Z J Obstet Gynaecol 2008; 48:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/72\">",
"      Levi M, Levy JH, Andersen HF, Truloff D. Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med 2010; 363:1791.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/73\">",
"      Alfirevic Z, Elbourne D, Pavord S, et al. Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European registry 2000-2004. Obstet Gynecol 2007; 110:1270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/74\">",
"      Pacheco LD, Saade GR, Gei AF, Hankins GD. Cutting-edge advances in the medical management of obstetrical hemorrhage. Am J Obstet Gynecol 2011; 205:526.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/75\">",
"      Rossaint R, Bouillon B, Cerny V, et al. Management of bleeding following major trauma: an updated European guideline. Crit Care 2010; 14:R52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/76\">",
"      Hess JR, Lawson JH. The coagulopathy of trauma versus disseminated intravascular coagulation. J Trauma 2006; 60:S12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/60/41929/abstract/77\">",
"      Sagraves SG, Toschlog EA, Rotondo MF. Damage control surgery--the intensivist's role. J Intensive Care Med 2006; 21:5.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6714 Version 23.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-89.32.226.102-A7B55BFC08-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_60_41929=[""].join("\n");
var outline_f40_60_41929=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H20\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INITIAL INTERVENTIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Fundal massage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Intravenous access",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3592966\">",
"      Oxygenation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Laboratory tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Uterotonic drugs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Fluid resuscitation and transfusion",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3593035\">",
"      - Crystalloid",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3593077\">",
"      - Transfusion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      SECONDARY INTERVENTIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Provide adequate anesthesia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Examine the vagina and cervix",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Exclude uterine rupture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Remove retained products of conception",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Uterine tamponade",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Balloons",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Packs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Arterial embolization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Recombinant activated factor VII",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      INDICATIONS FOR LAPAROTOMY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Hysterectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/6714\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/6714|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?1/25/1439\" title=\"diagnostic image 1A\">",
"      Angiogram showing postpartum hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?18/58/19360\" title=\"diagnostic image 1B\">",
"      Angiogram after embolization for postpartum hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/6714|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?11/39/11903\" title=\"figure 1\">",
"      Gelpi retractor",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?33/44/34498\" title=\"figure 2\">",
"      Heaney retractor",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?25/62/26607\" title=\"figure 3\">",
"      Breisky Navratil retractors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/6714|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?22/39/23166\" title=\"table 1\">",
"      Steps in management of postpartum hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?41/3/42043\" title=\"table 2\">",
"      Blood replacement products",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?30/26/31148\" title=\"table 3\">",
"      Interventions for Rx of PPH",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/10/5290?source=related_link\">",
"      Choosing the route of delivery after cesarean birth",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/44/23242?source=related_link\">",
"      Coagulopathy associated with trauma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/2/44071?source=related_link\">",
"      Evaluation and management of lower genital tract trauma in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/52/5961?source=related_link\">",
"      Indications for red cell transfusion in the adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/55/29562?source=related_link\">",
"      Initial evaluation and management of shock in adult trauma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/44/30408?source=related_link\">",
"      Interventional radiology in management of gynecological disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/11/22711?source=related_link\">",
"      Intrauterine balloon tamponade for control of postpartum hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/44/27336?source=related_link\">",
"      Management of postpartum hemorrhage at cesarean delivery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/25/38294?source=related_link\">",
"      Massive blood transfusion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/38/42600?source=related_link\">",
"      Overview of postpartum hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?37/15/38129?source=related_link\">",
"      Patient information: Postpartum hemorrhage (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/43/29367?source=related_link\">",
"      Peripartum hysterectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/34/8743?source=related_link\">",
"      Puerperal uterine inversion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/46/10986?source=related_link\">",
"      The approach to the patient who refuses blood transfusion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/13/31962?source=related_link\">",
"      Therapeutic uses of recombinant coagulation factor VIIa",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/37/21081?source=related_link\">",
"      Use of red blood cells for transfusion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/42/41639?source=related_link\">",
"      Uterotonic drugs for management of the third stage of labor",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_60_41930="Prehospital chest pain STEMI flow sheets";
var content_f40_60_41930=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F57981&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F57981&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 643px\">",
"   <div class=\"ttl\">",
"    Example of prehospital chest pain and STEMI flow sheets",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 623px; height: 797px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    AMI: acute myocardial infarction; COPD: chronic obstructive pulmonary disease; ECG: electrocardiogram; EMS: emergency medical system; EMT: emergency medical technician (B: basic EMT); NS: normal saline; P: paramedic;&nbsp;SBP: systolic blood pressure; STEMI: ST elevetion myocardial infarction",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Henderson McGinnis, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_60_41930=[""].join("\n");
var outline_f40_60_41930=null;
var title_f40_60_41931="Verbal relationship building";
var content_f40_60_41931=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F64050&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=13\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F64050&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=13\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Verbal relationship building skills",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Strategy (PEARLS)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Description",
"       </td>",
"       <td class=\"subtitle1\">",
"        Examples",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Partnership",
"       </td>",
"       <td>",
"        Joint problem solving",
"       </td>",
"       <td>",
"        \"Let's tackle this together.\"",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Empathy",
"       </td>",
"       <td>",
"        Show understanding; put feelings into words",
"       </td>",
"       <td>",
"        \"That sounds hard.\" \"You look upset.\" \"You seem",
"discouraged.\" \"Wow!\"",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Apology (compassion)",
"       </td>",
"       <td>",
"        Show concern for \"faux pas,\" hurts, bumbles",
"       </td>",
"       <td>",
"        \"I'm sorry I (or others) hurt/offended/ annoyed you.\"",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Respect",
"       </td>",
"       <td>",
"        Value patient's choices, traits and behaviors",
"       </td>",
"       <td>",
"        \"I appreciate your...(courage, decision, action).\" \"You",
"have worked hard on this.\"",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Legitimization",
"       </td>",
"       <td>",
"        Normalize and validate feeling and choices",
"       </td>",
"       <td>",
"        \"Anyone would be...(confused, sad,",
"irritated) by this situation.\"",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Support",
"       </td>",
"       <td>",
"        Offer ongoing personal support",
"       </td>",
"       <td>",
"        \"I'll stick with you as long as necessary.\"",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     Resist the powerful temptation to pursue clinical details when responding to a patient's emotion. Avoid actions that tend to make people feel ignored or irritated, such as judging, being defensive, persistent questioning, giving nonverbal cues of irritation, or prematurely giving information, advice or reassurance.",
"    </div>",
"    <div class=\"reference\">",
"     Adapted by permission from Clark W, Hewson M, Fry M, et al. American Academy on Physician and Patient (AAPP) 1998.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_60_41931=[""].join("\n");
var outline_f40_60_41931=null;
var title_f40_60_41932="Serologic markers HBV";
var content_f40_60_41932=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F60627&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F60627&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Serologic markers for the different phases of acute and chronic hepatitis B virus infection",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        HBsAg",
"       </td>",
"       <td class=\"subtitle1\">",
"        HBeAg",
"       </td>",
"       <td class=\"subtitle1\">",
"        IgM anti-HBc",
"       </td>",
"       <td class=\"subtitle1\">",
"        IgG anti-HBc",
"       </td>",
"       <td class=\"subtitle1\">",
"        Anti- HBs",
"       </td>",
"       <td class=\"subtitle1\">",
"        Anti- HBe",
"       </td>",
"       <td class=\"subtitle1\">",
"        HBV DNA",
"       </td>",
"       <td class=\"subtitle1\">",
"        Interpretation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"8\">",
"        Acute HBV infection",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +++",
"       </td>",
"       <td>",
"        Early phase",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        Window phase",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &plusmn;",
"       </td>",
"       <td>",
"        Recovery phase",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"8\">",
"        Chronic HBV infection",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +++",
"       </td>",
"       <td>",
"        Replicative phase",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &plusmn;",
"       </td>",
"       <td>",
"        Low, nonreplicative phase",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        +",
"       </td>",
"       <td>",
"        &plusmn;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        Flare of chronic HBV",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        Precore/core promoter mutants",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        -",
"       </td>",
"       <td>",
"        &nbsp;-",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;-",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        Occult HBV",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_60_41932=[""].join("\n");
var outline_f40_60_41932=null;
var title_f40_60_41933="Fingertip bruises 2";
var content_f40_60_41933=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F61566&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F61566&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Fingertip bruises",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 216px; height: 144px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Note the oval shaped bruises on the child's upper arm and forearm.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Joan E Shook, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_60_41933=[""].join("\n");
var outline_f40_60_41933=null;
var title_f40_60_41934="Mycobacterium avium adenitis";
var content_f40_60_41934=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F69475&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F69475&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mycobacterium avium adenitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 203px; height: 274px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <em>",
"     Mycobacterium avium",
"    </em>",
"    cervical lymphadenitis in the parotid and submandibular regions. The parotid node underwent incomplete excision and began to relapse. The submandibular node began to spontaneously drain and formed an overlying scab.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_60_41934=[""].join("\n");
var outline_f40_60_41934=null;
var title_f40_60_41935="NLD obstruction mattering";
var content_f40_60_41935=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F52654&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F52654&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Left nasolacrimal duct obstruction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 401px; height: 172px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The child's parents complained of epiphora of both eyes since the child's birth. The right eye cleared spontaneously, but the left eye continued to tear, with morning crusting and heavy mattering.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Tasman W, Jaeger E. The Wills Eye Hospital Atlas of Clinical Ophthalmology, 2nd ed. Lippincott Williams &amp; Wilkins, 2001. Copyright &copy; 2001 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_60_41935=[""].join("\n");
var outline_f40_60_41935=null;
